1
1 |
UNITED STATES FEDERAL TRADE COMMISSION
|
2 |
and
|
3 |
UNITED STATES DEPARTMENT OF JUSTICE
|
4 |
|
5 |
|
6 |
|
7 |
SHERMAN ACT SECTION 2 JOINT HEARINGS
|
8 |
UNDERSTANDING SINGLE-FIRM BEHAVIOR:
|
9 |
REMEDIES
|
10 |
THURSDAY, MARCH 29, 2007
|
11 |
|
12 |
|
13 |
|
14 |
|
15 |
HELD AT:
|
16 |
UNITED STATES FEDERAL TRADE COMMISSION
|
17 |
6TH & PENNSYLVANIA AVENUE, N.W.
|
18 |
WASHINGTON, D.C.
|
19 |
|
20 |
|
21 |
|
22 |
|
23 |
|
24 |
|
25 |
|
2
1 |
A P P E A R A N C E S
|
2 |
|
3 |
|
4 |
|
5 |
REMEDY IN THE FACE OF TECHNOLOGICAL CHANGE
|
6 |
|
7 |
|
8 |
MODERATORS:
|
9 |
Douglas Hilleboe, Federal Trade Commission
|
10 |
Ed Eliasberg, U.S. Department of Justice
|
11 |
|
12 |
|
13 |
PANELISTS:
|
14 |
Michael Cunningham, Red Hat, Inc.
|
15 |
Renata B. Hesse, Wilson Sonsini
|
16 |
Marina Lao, Seton Hall Law School
|
17 |
William H. Page, University of Florida
|
18 |
Howard A. Shelanski, UC Berkeley
|
19 |
|
20 |
|
21 |
|
22 |
|
23 |
|
24 |
|
25 |
|
3
1 |
P R O C E E D I N G S
|
2 |
- - - - -
|
3 |
MR. HILLEBOE: Good morning, everyone, thank you
|
4 |
for coming. I'm Doug Hilleboe, attorney with the
|
5 |
Federal Trade Commission, Office of the General Counsel,
|
6 |
I'm going to be one of the moderators here today for
|
7 |
this third session on remedies. My co-moderator is Ed
|
8 |
Eliasberg, he's an attorney with the U.S. Department of
|
9 |
Justice, Legal Policy Section of the Antitrust Division.
|
10 |
Before we start, I need to go over a few
|
11 |
housekeeping matters. As a courtesy to our speakers,
|
12 |
please turn off your cell phones, Blackberries and other
|
13 |
devices that make a noise, and I'll ask the speakers to
|
14 |
do the same, they actually interfere with the
|
15 |
microphones and we had a little problem with that.
|
16 |
Second, the restrooms are located down the hall,
|
17 |
through the double doors that you came through. Third,
|
18 |
in the unlikely event that the building alarms go off,
|
19 |
please proceed calmly and quickly, as instructed. If we
|
20 |
must leave the building, take the stairway which is to
|
21 |
the right, on Pennsylvania -- on the Pennsylvania side,
|
22 |
and after leaving the building, follow the stream of FTC
|
23 |
people and meet at the sculpture garden, which is across
|
24 |
from the intersection of Constitution Avenue and 7th
|
25 |
Street. |
4
1 |
Also, we must enforce our rule that there's no
|
2 |
questions or comments that come from the audience during
|
3 |
the session. Thank you.
|
4 |
We're honored today to have assembled a
|
5 |
distinguished group of panelists that have agreed to
|
6 |
offer their testimony in connection with this hearing on
|
7 |
remedies in the face of technology change.
|
8 |
Howard Shelanski is an associate dean and
|
9 |
professor of law at the University of California,
|
10 |
Berkeley, and the director of the Berkeley Center For
|
11 |
Law and Technology.
|
12 |
Renata Hesse is a partner at Wilson Sonsini
|
13 |
Goodrich and Rosati, and formerly was a chief of the
|
14 |
Networks and Technology Enforcement Section At the
|
15 |
Antitrust Division.
|
16 |
Michael Cunningham is general counsel at Red
|
17 |
Hat, Inc.
|
18 |
William Page is a Marshall M. Criser eminent
|
19 |
scholar at the University of Florida's Levin College of
|
20 |
Law.
|
21 |
And Marina Lao is a professor of law at Seton
|
22 |
Hall Law School.
|
23 |
We plan to hear from each of the speakers for
|
24 |
about 15 minutes each and then take a ten-minute break
|
25 |
and then we'll hear from the remaining speakers. We |
5
1 |
will then have the speakers comment upon what they've
|
2 |
heard, and then have a moderated discussion among the
|
3 |
speakers with Ed and I leading the discussion.
|
4 |
Before starting, I would just like to state by
|
5 |
way of introduction that many of the product markets in
|
6 |
which the United States enjoys a comparative advantage,
|
7 |
vis-a-vis the rest of the world, are fast-changing
|
8 |
dynamic markets, including high technology markets.
|
9 |
Some critics of the antitrust laws have claimed that the
|
10 |
laws, including Section 2, are not nimble enough for
|
11 |
effective use in these types of markets. Others
|
12 |
disagree. We will explore this issue and others in this
|
13 |
session.
|
14 |
Some commentators have suggested that the
|
15 |
potential for error in antitrust enforcement may be
|
16 |
greater in these dynamic markets; however, other
|
17 |
commentators have suggested that due to network effects
|
18 |
and other possible factors, these markets may tend
|
19 |
towards monopolization to a greater agree and therefore
|
20 |
perhaps deserve particular antitrust scrutiny.
|
21 |
We are interested to learn what these panelists
|
22 |
believe about these and other issues, and their
|
23 |
implications for antitrust enforcement in Section 2
|
24 |
cases.
|
25 |
Before beginning with the speakers, my |
6
1 |
co-moderator, Ed Eliasberg has some words about the
|
2 |
hearing.
|
3 |
MR. ELIASBERG: Thank you, Doug. I very briefly
|
4 |
on behalf of the Antitrust Division plan to welcome our
|
5 |
panelists, thank you for coming and we look -- we're
|
6 |
very much looking forward to hearing what you have to
|
7 |
say.
|
8 |
So, with that, Ed, let me turn back to you.
|
9 |
MR. HILLEBOE: Thank you, Doug. Howard
|
10 |
Shelanski is the Associate Dean and Professor of Law,
|
11 |
Boalt Hall, University of California, Berkeley and the
|
12 |
Director of the Berkeley Center for Law and Technology.
|
13 |
From 1999 to 2000, he served as chief economist of the
|
14 |
Federal Trade Commission -- Federal Communications
|
15 |
Commission, excuse me, and from 1998 to 1999, he served
|
16 |
as senior economist for the President's Council of
|
17 |
Economic Advisors At the White House.
|
18 |
Howard?
|
19 |
MR. SHELANSKI: Thanks, Doug, and I appreciate
|
20 |
the promotion. Well, I have a few main points that I
|
21 |
want to make and the points that I am going to make I
|
22 |
hope connect to what my co-panelists are going to say.
|
23 |
We had a call a week ago and I just want to set
|
24 |
up a few ideas here about the implications of the
|
25 |
implementation of remedies for monopolization in a |
7
1 |
high-tech or technologically dynamic markets. And I
|
2 |
think my main point, my overall point would be this:
|
3 |
Remedies are hard in the best of circumstances, and I
|
4 |
think they become more complicated in technologically
|
5 |
dynamic settings, but I also think that innovation and
|
6 |
the presence of ongoing innovation in a market may
|
7 |
affect remedies in somewhat unpredictable ways, and may
|
8 |
create opportunities along with the challenges.
|
9 |
In particular, I think while innovation makes
|
10 |
structural remedies more difficult, it may in some cases
|
11 |
make conduct remedies particularly valuable. So, I
|
12 |
think while innovative markets are cause for agencies
|
13 |
and courts to be more cautious about remedies, I think
|
14 |
innovation is not cause for systematic retreat from
|
15 |
enforcement or from behavioral injunctions.
|
16 |
So, let me explain a little bit why I think this
|
17 |
is the case. You'll hear, and I think one often hears
|
18 |
that structural remedies are preferable to conduct
|
19 |
remedies or behavioral remedies in monopolization cases.
|
20 |
But, there are some caveats to this. First I would say
|
21 |
that structural remedies are not always available.
|
22 |
Where a firm is so integrated that there are not obvious
|
23 |
divisions, it's very hard to know how to implement a
|
24 |
structural remedy. Just as a classic example, the
|
25 |
District Court's second opinion in the United Shoe |
8
1 |
machinery case would be an example.
|
2 |
The second caveat I would have is that
|
3 |
structural remedies are not always easier than conduct
|
4 |
or behavioral remedies, and in fact must often include
|
5 |
some supporting behavioral remedies, and as an example,
|
6 |
I would talk about the AT&T vertical divestiture that
|
7 |
had to be implemented by open access regulations
|
8 |
enforced by the FCC and overseen by the District Court.
|
9 |
And then, finally, I would say as a general
|
10 |
caveat, the effectiveness of structural remedies in
|
11 |
Section 2 cases is not assured and there's certainly
|
12 |
quite a bit of debate of effectiveness historically over
|
13 |
structural remedies. I'll give you a couple of
|
14 |
examples. One early quotation, "In administering the
|
15 |
antitrust acts, a number of great and powerful defenses
|
16 |
against them have been dissolved. So far as is possible
|
17 |
to judge the consuming public has not yet greatly
|
18 |
profited by their dissolution." That's Judge Rose in
|
19 |
United States against American Can in 1916.
|
20 |
Okay, now, we haven't had a lot of experience in
|
21 |
enforcing Section 2 by 1916, so maybe things have
|
22 |
changed, at least some people disagree. Bob Crandell in
|
23 |
2003 writes, divestitures are "costly exercises in
|
24 |
futility," but I would point you to the excellent work
|
25 |
of John Baker and Greg Werden in 2003 providing some |
9
1 |
counter arguments. Just a way of saying effective
|
2 |
remedies structurally offer no guarantee of success.
|
3 |
Now, I think the structural remedies may
|
4 |
actually be even harder in technologically dynamic
|
5 |
markets, and let me offer a couple of reasons. First,
|
6 |
where a firm or industry is driven by R&D, it may do no
|
7 |
good to divest a given division or to leave a company in
|
8 |
two without sending the R&D operations with the divested
|
9 |
portions of the entity, but R&D operations are often,
|
10 |
perhaps even likely, to be more integrated and
|
11 |
inter-dependent within the firm and not susceptible to
|
12 |
clean lines of separation.
|
13 |
The second reason why I think the presence of
|
14 |
ongoing technological change may make structural
|
15 |
remedies difficult is that even if divestiture is
|
16 |
possible, high-tech firms may require more monitoring of
|
17 |
conduct during after the divestiture, because key assets
|
18 |
in such divestiture are likely to be intellectual
|
19 |
property, IP that in some cases may provide joint uses,
|
20 |
uses across the lines of the new or divested entities,
|
21 |
disputes are likely to be offered over what items to
|
22 |
transfer and whether all IP has been disclosed to the
|
23 |
new entity.
|
24 |
Moreover, because of the cooperative nature of
|
25 |
research and development, and in production, in markets |
10
1 |
where product life cycles are short, some post
|
2 |
divestiture monitoring of relationships between newly
|
3 |
distinct entities may be needed because there may be a
|
4 |
natural incentive to favor each other as business
|
5 |
partners, and that was something that came up in the
|
6 |
wake of the AT&T divestiture, for example.
|
7 |
The third reason I think that fast technological
|
8 |
change renders structural remedies more challenging is
|
9 |
that firm and market structure may be less of an issue,
|
10 |
in some technologically dynamic markets. To the extent
|
11 |
that the so-called Schumpeterian School is correct, that
|
12 |
dynamic markets often display competition that occurs
|
13 |
sequentially, through periodic waves of creative
|
14 |
destruction, rather than concurrently, through
|
15 |
simultaneous production, divestitures may be less
|
16 |
effective or necessary such markets, although this is
|
17 |
probably more true for horizontal than for vertical
|
18 |
divestitures.
|
19 |
Okay, and my final reason that structural
|
20 |
remedies are tough in technologically dynamic markets,
|
21 |
is that where network effects are at issue, structural
|
22 |
issues might harm consumers by dissipating positive
|
23 |
network externalities. The fact that it might have been
|
24 |
better not to have monopoly in the first place does not
|
25 |
always mean it is better to break up the monopoly later, |
11
1 |
and if such divestitures are to preserve network
|
2 |
externalities, they may have to be accompanied by
|
3 |
conduct remedies related to interconnection and
|
4 |
interoperability, doing away with those clean properties
|
5 |
of structural remedies.
|
6 |
Okay, let me turn now to conduct remedies, talk
|
7 |
a little bit about how they might work in high-tech
|
8 |
markets. As a general matter, we often hear that
|
9 |
conduct remedies are difficult, but there are some
|
10 |
caveats here as well. Not all conduct remedies are
|
11 |
created equal, and as many people have pointed out,
|
12 |
negative prohibitions, thou shalt not have exclusive
|
13 |
deals, for example, are probably easier to implement
|
14 |
than affirmative obligations, thou shall deal with your
|
15 |
rivals. In part because the negative prohibitions
|
16 |
entail less involvement of courts or agencies in
|
17 |
regulating terms of trade.
|
18 |
The second caveat that I would add is that
|
19 |
conduct remedies can have beneficial prospective impact,
|
20 |
even if they cannot roll back illegally accumulated or
|
21 |
prolonged market power. Some people say, look, conduct
|
22 |
remedies are closing the barn doors after the cows are
|
23 |
out, but if there are still some cows inside the barn,
|
24 |
it's not a bad idea to shut the door.
|
25 |
Third, even if a conduct remedy is ineffective |
12
1 |
or weak in a given case, I think conduct remedies can
|
2 |
have important deterrent effects on others contemplating
|
3 |
the illegal behavior, and it's -- in a point that's
|
4 |
often made, some people say, if you can't be sure that
|
5 |
your conduct remedy is going to be effective, why bring
|
6 |
the case? Another reason to bring the case beyond
|
7 |
deterrence is I think as we get more experience with
|
8 |
different kinds of conduct, it can become clearer what
|
9 |
is good and what is bad, and it enables agencies to move
|
10 |
more quickly in subsequent cases, and perhaps get a
|
11 |
remedy implemented while the harm is still able to be --
|
12 |
to be nipped in the bud, so I would not let lack of a
|
13 |
clearly successful conduct remedy -- I think one needs
|
14 |
to be clearly articulable at the start of a case, but if
|
15 |
you can't be sure it will be implemented in time or it
|
16 |
will be successful in remedying the market power, there
|
17 |
may be some reasons to go ahead with the case anyway in
|
18 |
terms of establishing precedent and creating deterrence
|
19 |
effects.
|
20 |
And finally, just an observation, I think that
|
21 |
the effectiveness of conduct remedies are likely to --
|
22 |
the effectiveness is likely to be tied to the precision
|
23 |
with which one can define the cause of anticompetitive
|
24 |
harm, and in some cases, this can be done quite clearly,
|
25 |
and in those cases, I think behavioral injunctions can |
13
1 |
be quite effective.
|
2 |
So, the overall lesson about conduct remedies, I
|
3 |
think that it is right to be weary of behavioral
|
4 |
remedies, particularly those in which the enjoined
|
5 |
conduct has ambiguous welfare effects, or in which
|
6 |
courts or agencies will have to become involved that
|
7 |
were doing terms of trade, but in the right context,
|
8 |
conduct remedies can work and can send valuable
|
9 |
deterrent signals.
|
10 |
I would just say that inability to articulate a
|
11 |
structural remedy therefore should not be decisive in
|
12 |
whether or not to prosecute an argument that is
|
13 |
sometimes heard.
|
14 |
Okay. Well, I think that technologically
|
15 |
dynamic markets create both challenges and opportunities
|
16 |
for implementing conduct remedies. The first challenge
|
17 |
is this: If one accepts that remedies may deter
|
18 |
marginal innovation, and I'll assume for the moment that
|
19 |
all innovation is good, because private returns are less
|
20 |
than social returns to innovation. Let's just take that
|
21 |
as a working assumption, it need not be true in all
|
22 |
cases, but if one accepts that, and one accepts that
|
23 |
remedies can marginally deter innovation, then the
|
24 |
deterrence risk and the costs of such deterrence may be
|
25 |
much greater in dynamic markets. It needn't be the |
14
1 |
case, but I think innovation deterrence becomes a more
|
2 |
salient issue and a more salient concern in
|
3 |
technologically dynamic markets.
|
4 |
The second challenge is that in fast-changing
|
5 |
markets, it is more likely than it is in more static
|
6 |
settings that the conduct at issue in the case will be
|
7 |
moot by the time antitrust liability is established.
|
8 |
And in such cases, neither conduct nor structural
|
9 |
remedies are likely to be effective, and perhaps
|
10 |
something else like disgorgement might be called for if
|
11 |
such a remedy can be created.
|
12 |
But there are also opportunities in high
|
13 |
technology settings, I think, for conduct remedies to be
|
14 |
particularly effective. In some cases, technological
|
15 |
dynamics can render conduct remedies effective where
|
16 |
they would not be in more static markets.
|
17 |
In some cases, monopoly once obtain may not be
|
18 |
easily eroded, even if exclusionary or predatory conduct
|
19 |
that contributed to that monopoly is stopped. Whether
|
20 |
because of brand recognition, economies of scale, or
|
21 |
customer switching costs, new entrants will be slow to
|
22 |
appear or succeed, even when other barriers to entry,
|
23 |
such as the exclusionary or predatory conduct at issue
|
24 |
in the case, even when those barriers are eliminated,
|
25 |
you might not see competition arising. |
15
1 |
But I think where competition is more innovation
|
2 |
based and where product life cycles are short, an
|
3 |
injunction against the behavior that led to the
|
4 |
establishment or maintenance of monopoly power may prove
|
5 |
very effective, as it is the latter set of barriers,
|
6 |
rather than any brand or economic advantage, that might
|
7 |
have kept the incumbent dominant.
|
8 |
As new waves of innovation come forward, how did
|
9 |
they stop someone else from being the innovator who came
|
10 |
in with the new product? Well, through the exclusionary
|
11 |
or predatory conduct, and branded here and switching
|
12 |
costs, other things like that, may be very, very
|
13 |
different in the high-tech environment. So, merely
|
14 |
eliminating the harmful conduct may open the door for
|
15 |
new entry and the conduct or remedy, particularly
|
16 |
negative injunctions, I think, can be very successful
|
17 |
and very helpful.
|
18 |
I would like to just raise an additional point
|
19 |
about the overall question of whether or not the cycles
|
20 |
of innovation move so quickly and the innovation process
|
21 |
moves in such different a way from the standard
|
22 |
competitive process that we should step back generally
|
23 |
from antitrust enforcement, and this is an argument that
|
24 |
one hears quite often.
|
25 |
I think when one looks at the kinds of behavior |
16
1 |
that limit innovation, and that stop people -- that stop
|
2 |
competitors from innovating, it's very unclear to me
|
3 |
whether or not monopoly has anything particular to
|
4 |
recognize it, nor is it clear to me that new waves of
|
5 |
innovation are always going to be sufficiently powerful
|
6 |
to overcome artificial barriers to entry like
|
7 |
exclusionary -- exclusionary kinds of behavior like
|
8 |
exclusive deals when it is a monopolist that has that
|
9 |
exclusive deal, contractual terms that bar competitors'
|
10 |
products from ever being used, tying that prevents
|
11 |
consumers from ever having access to products.
|
12 |
It's unclear to me no innovation will always be
|
13 |
so great that it can overcome those barriers, those
|
14 |
barriers can lead to slower product life cycles, and
|
15 |
greatly harm consumers, and I think that there's a lot
|
16 |
of evidence of benefits from antitrust enforcement in
|
17 |
high-tech areas. And when one looks at the studies that
|
18 |
have said there are no benefits to Section 2
|
19 |
enforcement, or in a more nuance way, no benefits to
|
20 |
Section 2 enforcement in technologically dynamic
|
21 |
markets, there's a counterfactual, all of these papers
|
22 |
acknowledge the counterfactual, and we can't tell what
|
23 |
would have happened absent the antitrust enforcement, we
|
24 |
can't tell what would have happened in other markets had
|
25 |
there been antitrust enforcement, and then those |
17
1 |
arguments are sort of dismissed, tucked under the
|
2 |
carpet.
|
3 |
I wouldn't dismiss them so easily. And, so, my
|
4 |
overall argument would be, be very cautious, be very
|
5 |
case-by-case in the application of Section 2 remedies in
|
6 |
high-tech markets, I think structural remedies are
|
7 |
likely to be harder to implement, but there may be good
|
8 |
opportunities for conduct remedies to be very effective.
|
9 |
Thanks.
|
10 |
(Applause.)
|
11 |
MR. HILLEBOE: Thank you very much, Howard. Our
|
12 |
next speaker, excuse me, is Renata Hesse, who is a
|
13 |
partner at Wilson Sonsini Goodrich and Rosati. Prior to
|
14 |
joining Wilson Sonsini, Renata served as the chief of
|
15 |
the Networks and Technology Enforcement Section at the
|
16 |
Antitrust Division and oversaw much of the division's
|
17 |
technology litigation, including the Oracle/Peoplesoft
|
18 |
and First Data/Concord matters. In addition, Renata
|
19 |
worked extensively on both the American Airlines and the
|
20 |
Microsoft case.
|
21 |
Renata?
|
22 |
MS. HESSE: Getting myself around is a little
|
23 |
harder these days.
|
24 |
So, Howard covered a lot of ground which I think
|
25 |
fundamentally I agree with almost everything he said. |
18
1 |
In fact, I think I probably agree with everything he
|
2 |
said, but wanted to pick up where he was leaving off,
|
3 |
which was I think in talking about the notion that you
|
4 |
shouldn't back away from Section 2 enforcement in high
|
5 |
technology markets, and the main reason why I think
|
6 |
that's true is that despite all of the innovation and
|
7 |
the fast pace of change in those markets, there is an
|
8 |
opportunity for durable market power to exist in them,
|
9 |
and you do want to make sure that you're not overlooking
|
10 |
that possibility and potentially addressing it.
|
11 |
So, I wanted to start with just a few basic
|
12 |
points about Section 2 remedies that I think are
|
13 |
important, and some of these overlap with some of the
|
14 |
things that Howard said and I'm sure that will happen as
|
15 |
we go along down the line of speakers, but the first
|
16 |
thing that I wanted to talk about is the importance of
|
17 |
focusing on remedy early, and the main reason -- there
|
18 |
are several reasons for that, but the biggest reason is
|
19 |
that it helps you try to figure out what your goal is.
|
20 |
What's the violation that you're really thinking about,
|
21 |
what do you think has really happened that's harmful,
|
22 |
and how can you address it? That isn't to say that if
|
23 |
you can't come up with a perfect solution to the problem
|
24 |
that you shouldn't go ahead and try and do something
|
25 |
about it. |
19
1 |
I think Howard is right that there's a good
|
2 |
deterrent effect in enforcing the law, even if you're
|
3 |
not 100 percent sure that the way that you think you can
|
4 |
fix it will be successful, but I do think it will -- it
|
5 |
helps you focus your investigation, and here again, I'm
|
6 |
speaking as if I were a government lawyer, but focus
|
7 |
your investigation and theories so that you can really
|
8 |
figure out whether or not you've got a case that is
|
9 |
worth allocating resources to, and pursuing.
|
10 |
And I just think it gives you a much better
|
11 |
sense of the definition of the harm that you're trying
|
12 |
to alleviate.
|
13 |
The second point is that I think when you start
|
14 |
with thinking about remedy, or at least you think about
|
15 |
remedy relatively early in the process, you can get a
|
16 |
better sense for whether or not you actually can come up
|
17 |
with a remedy that is really going to leave the
|
18 |
marketplace in a better place than it was when you
|
19 |
started.
|
20 |
And I would sort of call this the first do no
|
21 |
harm rule, and it is one of these things which you
|
22 |
always need to bear in mind, which is that you don't
|
23 |
always want to make things worse, you don't want to
|
24 |
deter innovation or take an action in the marketplace
|
25 |
which stifles productivity, and I think in technology |
20
1 |
markets, that's something that you really need to keep
|
2 |
in mind.
|
3 |
But if you were stepping back and thinking about
|
4 |
that early, you can think about whether or not there are
|
5 |
ways to achieve the goal that you want to achieve
|
6 |
without having at least a large countervailing harmful
|
7 |
effect.
|
8 |
The third point is related to the resource
|
9 |
allocation point that I made. I think fundamentally
|
10 |
it's just a basic responsibility that particularly
|
11 |
government enforcers have to think about how you're
|
12 |
going to fix the problem, and whether or not the problem
|
13 |
is subject to a fix that's worth the investment of
|
14 |
resources in not only the investigation and prosecution
|
15 |
of the matter, but also the compliance and enforcement
|
16 |
activities that will happen post judgment, and those
|
17 |
are, I think, much more complicated when you're talking
|
18 |
about conduct remedies and structural remedies, but,
|
19 |
again, Howard correctly notes that when you do a
|
20 |
structural remedy in these markets, very often there are
|
21 |
going to be conduct remedies associated with it in any
|
22 |
event.
|
23 |
But I think you really do want to have in your
|
24 |
mind whether or not the consumption of the resource is
|
25 |
likely to result in some improvement to the competitive |
21
1 |
conditions in the marketplace.
|
2 |
And then there's a fourth point which is that
|
3 |
sort of the question of if you have a good idea of what
|
4 |
you think the remedy that you want to put into place is,
|
5 |
then I think you'll have a better idea of whether or not
|
6 |
the -- again, the pursuit of the investigation or
|
7 |
prosecution is worth while, and by that I mean that
|
8 |
there are some kinds of Section 2 violations that are
|
9 |
easier to remedy than others.
|
10 |
So, one example might be you can think of
|
11 |
exclusive dealing or vertical foreclosure, for example,
|
12 |
where you have fairly easily identifiable concrete types
|
13 |
of conduct that you can undo. I think monopoly
|
14 |
maintenance, to a certain degree, monopoly acquisition
|
15 |
cases are much harder.
|
16 |
So, if you're in the situation where you're
|
17 |
balancing these things out, and you've got a choice
|
18 |
between two matters that you want to devote your
|
19 |
resources to and one of them has a reasonably good
|
20 |
likelihood of being able to be fixed, and the other is a
|
21 |
little tougher, then you've got to figure out how to
|
22 |
allocate your resources, then you might want to think
|
23 |
about going towards the one that actually has a solution
|
24 |
that you can identify and that you think will be likely
|
25 |
to result in an improvement in the competitive |
22
1 |
conditions.
|
2 |
And this just goes back to something that I
|
3 |
think people often think about in the context of -- of
|
4 |
the -- when you're trying to come up with a remedy, what
|
5 |
is it that you're trying to achieve, are you looking at
|
6 |
a monopoly that you believe has been illegally created
|
7 |
and are you trying to undo that, or are you looking at
|
8 |
conduct that has maintained a monopoly and are you
|
9 |
trying to restore the conditions of the competitive
|
10 |
marketplace to the pre-exclusionary conduct state? And
|
11 |
depending on which of those two things you're looking
|
12 |
at, you're going to have a pretty different, I think,
|
13 |
idea about what's the right way to go about recommending
|
14 |
the harm.
|
15 |
The second thing I wanted to talk about was just
|
16 |
the point that Howard started with, which is structural
|
17 |
remedies and the general point that generally I think
|
18 |
structural remedies should be preferred. I think it's
|
19 |
clearly true that they are not always possible, and
|
20 |
that's certainly more true in Section 2 cases than in
|
21 |
other kinds of cases, but I wouldn't advise sort of
|
22 |
ignoring them as possible ways of recommending harm,
|
23 |
because I think they do have a number of benefits.
|
24 |
One of the benefits is that developing a
|
25 |
functional set of conduct restrictions that are likely |
23
1 |
to have a beneficial effect, without having this sort of
|
2 |
countervailing, potentially negative effect on the
|
3 |
marketplace is an extremely complicated and resource
|
4 |
intensive process. It took a really long time to come
|
5 |
up with the conduct restrictions that we developed in
|
6 |
the Microsoft case, and I think, you know, you can --
|
7 |
it's open for debate whether or not those were worked
|
8 |
well or not well, but it took a long time to figure them
|
9 |
out, and to just evaluate all the different
|
10 |
possibilities and try to develop language that's
|
11 |
concrete enough and understandable enough in a legal
|
12 |
document for people to actually then be able to
|
13 |
implement it and understand it and understand what the
|
14 |
rules of the road are. It's just an inherently
|
15 |
difficult process to do, and I think that isn't just
|
16 |
Microsoft, that's any time when you're trying to come up
|
17 |
with a set of conduct restrictions where you're dealing
|
18 |
with complex technology.
|
19 |
It's also hard to judge their success, I think,
|
20 |
and that's also true in structural remedies, in some
|
21 |
situations, but it's very hard to know when conduct
|
22 |
restrictions have succeeded. I think you can know when
|
23 |
they've failed, but I don't think you can know as easily
|
24 |
when they've succeeded. How do you measure success with
|
25 |
conduct restrictions? |
24
1 |
I think structural remedies generally eliminate,
|
2 |
although not entirely, the need for ongoing enforcement
|
3 |
in compliance activity, which also can be an extremely
|
4 |
time consuming and resource intensive process. It can
|
5 |
require, and this is something else I can talk about a
|
6 |
little bit later, but it can require a lot of assistance
|
7 |
from people who know more about technology and business
|
8 |
and licensing and all these things that come up in
|
9 |
technology markets work, and structural remedies tend to
|
10 |
need a lot less of that.
|
11 |
I think structural remedies are generally less
|
12 |
easy to evade. It's pretty clear what you're supposed
|
13 |
to do, and you've either done it or you haven't done it.
|
14 |
You've either divested the plant or the asset or
|
15 |
whatever it is, or you haven't. You know, there are
|
16 |
issues associated with those kinds of things, whether or
|
17 |
not you found an adequate buyer and all of those other
|
18 |
sorts of issues, but at least there's a very clear line
|
19 |
about what you are supposed to have done.
|
20 |
I think they have a potentially greater
|
21 |
deterrent effect, because they have the capability at
|
22 |
least of really restructuring a business in a way that
|
23 |
most businesses don't want to have happen. So, that can
|
24 |
discourage people from engaging in conduct that folks
|
25 |
think violates Section 2. |
25
1 |
And I think generally, again with some of the
|
2 |
caveats that Howard laid out, they're more likely to
|
3 |
work. The lines are clearer, and if you've actually
|
4 |
proven a violation where you can support imposition of a
|
5 |
structural remedy, I think the likelihood of that
|
6 |
structural remedy having an effect is probably higher.
|
7 |
So, those are some kind of basic points. A few
|
8 |
points that are more directly connected, just to sort of
|
9 |
the technology markets, and the first is, you know,
|
10 |
everybody always talks about technology markets are fast
|
11 |
changing and innovation changes everything, and as
|
12 |
Howard said, sometimes people say, maybe you don't need
|
13 |
to worry about them because they're just going to be
|
14 |
self correcting. I tend not to agree with that latter
|
15 |
viewpoint, for the reason that I started with, which is
|
16 |
that it's clear that there's a possibility for the
|
17 |
existence of durable market power in these markets, so I
|
18 |
think just leaving them alone and hoping that the
|
19 |
exclusionary conduct somehow magically stops and things
|
20 |
correct themselves is not likely to lead to a lot of
|
21 |
success.
|
22 |
I do think that the fact that they can sometimes
|
23 |
be slow and that the antitrust enforcement process can
|
24 |
sometimes be slow is a down side in these markets, a
|
25 |
greater down side in these markets than in other |
26
1 |
markets, because sometimes you feel like you get to the
|
2 |
end and you're addressing the problem when it's actually
|
3 |
a little bit too late.
|
4 |
As a consequence, I think you need, when you're
|
5 |
thinking about conduct remedies in technology markets,
|
6 |
to be a little bit more flexible about how you think
|
7 |
about them. And to address categories or types of
|
8 |
conduct relating to types or categories of products or
|
9 |
services as opposed to saying, well, this -- you did
|
10 |
this particular thing with this particular kind of
|
11 |
product, and you should do that -- you shouldn't do that
|
12 |
anymore. This is the negative prohibition point versus
|
13 |
an affirmative obligation point.
|
14 |
If the conduct remedy is too narrowly focused,
|
15 |
it runs the risk of being ineffective, and I think in
|
16 |
most cases is likely to be ineffective, particularly,
|
17 |
again, if you're talking about undoing some sort of harm
|
18 |
that has occurred.
|
19 |
You know, Microsoft is a simple example of this,
|
20 |
the consent decree doesn't just talk about browsers,
|
21 |
which was the primary focus of the case, but it talks
|
22 |
about other products which were potential platform
|
23 |
threats and has some construct restrictions in it that
|
24 |
are designed to try to go after those particular -- or
|
25 |
not go after them, but to try and make sure that the |
27
1 |
conduct relating to those other kind of potential
|
2 |
platform threats were restrained.
|
3 |
There's a possibility in technology markets that
|
4 |
they should be of shorter duration. Again, Microsoft is
|
5 |
another example, it was a five-year consent decree, it's
|
6 |
now been extended in some pieces for longer than that,
|
7 |
but I think there's a reasonable basis for at least
|
8 |
looking at the question of whether or not you really
|
9 |
need something to last ten, 20, some decrees in the past
|
10 |
have lasted for hundreds of years, some of them very
|
11 |
perpetual, and whether or not that makes sense
|
12 |
particularly in the context of technology markets is I
|
13 |
think something that people -- it's worth looking at.
|
14 |
I also think if you're going to think about
|
15 |
decrees of shorter durations, or remedies of shorter
|
16 |
durations, that including some mechanism for revisiting
|
17 |
that question before the term of the decree expires is a
|
18 |
good idea. I think it's just these markets are
|
19 |
inherently unpredictable, and given the complication of
|
20 |
structuring conduct provisions in them, that giving
|
21 |
yourself an opportunity to take a second look and having
|
22 |
a standard for how you would be able to convince a court
|
23 |
that you need to extend a decree in these kinds of
|
24 |
markets is something that should be given some
|
25 |
consideration. |
28
1 |
And the final point on this area is that I think
|
2 |
conduct remedies in Section 2, Section 2 remedies in
|
3 |
technology markets may need to be more forward looking,
|
4 |
and this is a little slightly basically the same thing
|
5 |
with a slightly different pitch on it, but you do have
|
6 |
to think about what it is that you can predict about the
|
7 |
marketplace and changes in the marketplace going forward
|
8 |
and whether or not what you've devised in the context of
|
9 |
the conduct remedy is adequate to address the changing
|
10 |
technology in the marketplace.
|
11 |
The last piece about technology markets that I
|
12 |
think makes them different is that they're hard, and
|
13 |
it's hard to understand them, and they're particularly
|
14 |
hard for people who are not educated in technology.
|
15 |
And, so, compliance monitoring enforcement can be a
|
16 |
difficult thing to do.
|
17 |
As a consequence, I think if you're looking at
|
18 |
these markets and you're looking at behavioral
|
19 |
restrictions, particularly ones that relate to licensing
|
20 |
of intellectual property or access to technology or
|
21 |
just, you know, you're requiring a company to stop doing
|
22 |
a particular activity with a particular type of
|
23 |
technology, that you really need to anticipate getting
|
24 |
some technical help, and when I think of technical help
|
25 |
in this context, I don't think just of software |
29
1 |
engineers or hardware engineers, but I also think of
|
2 |
licensing expertise, business expertise, you know,
|
3 |
trying to figure out whether a royalty ran is a
|
4 |
difficult problem, and it's not a problem that most
|
5 |
antitrust lawyers deal with on a day-to-day basis.
|
6 |
And having the ability to have access to people
|
7 |
who actually do that kind of work for a living, who know
|
8 |
what particular types of technologies, what kinds of
|
9 |
royalties particular types of technologies command is, I
|
10 |
think, critical to the ability to actually do an
|
11 |
adequate job of monitoring and enforcing compliance.
|
12 |
Again, I started with sort of a more broad
|
13 |
definition of technical assistance, but a narrow
|
14 |
definition of technical assistance, which is just
|
15 |
actually having somebody who knows how software code is
|
16 |
written, and what to look for and how to evaluate
|
17 |
whether or not something has been done in the code is
|
18 |
very important. I think one of the really unusual and
|
19 |
innovative things that was in the Microsoft decree was
|
20 |
the technical committee provision, which allowed the
|
21 |
Department of Justice and the states to have access to
|
22 |
basically a full-time group of technical consultants who
|
23 |
were hired to work for those people and the cost of
|
24 |
which was borne and continues to be borne by Microsoft.
|
25 |
I think it was an unusual idea, but it really |
30
1 |
has become, I think, a key component to the United
|
2 |
States enforcement and monitoring, compliance monitoring
|
3 |
efforts of the Microsoft decree, and it was essentially
|
4 |
copied by the European Commission in the work that
|
5 |
they're doing in Microsoft as well.
|
6 |
And it had not been done before. There were
|
7 |
lots of times where in complicated markets people had
|
8 |
used monitoring trustees, I shouldn't say there were
|
9 |
lots of times, but there were examples of monitoring
|
10 |
trustees being used, usually they were in things like
|
11 |
prison condition litigation, where there was some pretty
|
12 |
complicated oversight that was needed, but hiring
|
13 |
technical experts to help out was an innovative thing to
|
14 |
do and I think has proven to be a pretty successful
|
15 |
component of the Microsoft decree.
|
16 |
Now, you also may need technical assistance when
|
17 |
you're trying to figure out whether or not somebody has
|
18 |
violated the decree and you actually want to go after
|
19 |
them for contempt. I think the Microsoft model doesn't
|
20 |
quite fit so well in that context, because it's a little
|
21 |
hard to see how you can justify the party who you're
|
22 |
going to be pursuing in contempt actually paying for the
|
23 |
expert that you're going to be using, to go after them
|
24 |
in contempt, but it's something that people -- you want
|
25 |
to think about, and at least have the resources and |
31
1 |
capability to get that kind of help on board.
|
2 |
So, I have probably 30 seconds at this point
|
3 |
left. The last thing I would say is that licensing
|
4 |
remedies are incredibly common in technology markets.
|
5 |
They can be useful, and I think can work well, but I
|
6 |
think they work particularly well in the context where
|
7 |
you know or have a very good idea of what the
|
8 |
intellectual property is or what the asset is that needs
|
9 |
to be licensed, are there particular patents who needs
|
10 |
them, and again, if you go back at the very beginning,
|
11 |
to those are things that you can think about early on
|
12 |
and figure out and they'll help you determine whether or
|
13 |
not a licensing remedy is likely to be successful.
|
14 |
And of course when you're doing that, you need
|
15 |
to think about the policy issues that are associated
|
16 |
with compulsory licensing of intellectual property,
|
17 |
which is a hot topic these days.
|
18 |
(Applause.)
|
19 |
MR. HILLEBOE: Thank you so much, Renata, for
|
20 |
those comments.
|
21 |
Michael Cunningham is general counsel at Red
|
22 |
Hat, Inc. Prior to joining Red Hat, he served as
|
23 |
associate general counsel at IBM, where he had legal
|
24 |
advisory responsibilities for the Business Consulting
|
25 |
Services Division for Europe, the Middle East and |
32
1 |
Africa. He was also a partner and associate general
|
2 |
counsel at PricewaterhouseCoopers.
|
3 |
Michael?
|
4 |
MR. CUNNINGHAM: Thank you, and good morning.
|
5 |
I'm pleased to have the opportunity to participate in
|
6 |
this important consideration of Section 2 remedies, to
|
7 |
do so before distinguished representatives of the
|
8 |
government, as well as with this particularly
|
9 |
knowledgeable panel.
|
10 |
I'm the general counsel of Red Hat. I'm going
|
11 |
to make a little disclaimer, I'm a technology lawyer,
|
12 |
I'm not principally an antitrust lawyer. I hope that I
|
13 |
can offer some comments, however, as an executive of a
|
14 |
technology company that are relevant to these inquiries.
|
15 |
With your indulgence, I would like to describe a
|
16 |
bit about our business that I think is relevant
|
17 |
innovation, given the debate about antitrust remedies
|
18 |
stifling innovation, I think it's particularly
|
19 |
appropriate this morning.
|
20 |
The software solutions that Red Hat offers, and
|
21 |
for which we provide services, are developed by very
|
22 |
broad horizontal communities that are without
|
23 |
geographic, organizational or political boundaries. The
|
24 |
community of innovators that unleash the value of open
|
25 |
source are not contained within Red Hat. Some of its |
33
1 |
contributors are, but it's not.
|
2 |
The contributors include the customers and
|
3 |
vendors of hardware and software. It includes
|
4 |
academics, it includes many, many motivated individuals
|
5 |
that we call hackers, it includes persons from every
|
6 |
continent and from multiple political subdivisions.
|
7 |
The development environment is also not
|
8 |
controlled by any single individual company or political
|
9 |
entity, it is instead a free, meritocratic marketplace
|
10 |
of ideas. Individuals take these ideas and they place
|
11 |
these ideas with their individual name and reputation
|
12 |
into the marketplace in a particular software
|
13 |
development project to which their idea is relevant.
|
14 |
There are literally thousands of these projects
|
15 |
out there. In one of our offerings, Red Hat Enterprise
|
16 |
Linux, hundreds of projects are represented. These
|
17 |
ideas are then reviewed by that development community,
|
18 |
for that project, and only those ideas that can handle
|
19 |
the open scrutiny of this open source community are then
|
20 |
adopted.
|
21 |
In this way, the best ideas and the bets bits of
|
22 |
ideas bubble up. Moreover, if there happen to be a
|
23 |
serendipitous discovery that is made in one of those
|
24 |
projects that's relevant to another project or might be
|
25 |
an entirely new approach, the contributor or any other |
34
1 |
person is free to contribute it to that project or
|
2 |
indeed to go out and start a new project to take the
|
3 |
technology in a new direction.
|
4 |
This model has produced and continues to produce
|
5 |
copious innovation. It also accelerates and multiplies
|
6 |
innovation, I would argue, by providing tools of
|
7 |
innovation, such as information ideas to a broader and
|
8 |
more diverse community than development within any one
|
9 |
firm is possible could provide.
|
10 |
The open exchange of information and ideas is an
|
11 |
innovation force multiplier. For example, sophisticated
|
12 |
business and other users of software frequently take the
|
13 |
modular pieces of well crafted software that's developed
|
14 |
in the open source community, cobble bits and pieces of
|
15 |
it together, modify it, append to it and create
|
16 |
solutions for problems that heretofore were not solved,
|
17 |
or new problems that arise in their business.
|
18 |
Similarly, the creative juices of the lone
|
19 |
teenager in North Dakota in some remote location can
|
20 |
contribute to that process, so can a Cal Tech physicist
|
21 |
who is wondering why there hasn't been a software
|
22 |
development that would help in his or her research. And
|
23 |
so are many, many others unleashed in the creative
|
24 |
process through this open development and collaboration
|
25 |
model. |
35
1 |
The modular and open nature of open source
|
2 |
software has fueled much innovation, but it is by no
|
3 |
means limited to software. It is not a software-only
|
4 |
phenomena. No, I would submit to you that the relative
|
5 |
ubiquity and low cost of the Internet, and collaboration
|
6 |
tools like email and dedicated web sites portends for
|
7 |
joint collaboration that is unleashing all sorts of
|
8 |
innovation across the world.
|
9 |
If you've read the best selling book by Tom
|
10 |
Friedman, The World is Flat, you will get a very good
|
11 |
sense of some of these trends, I think. I would also be
|
12 |
happy to comment on some other areas where that
|
13 |
innovation is being unleashed in the questioning, if
|
14 |
that's helpful.
|
15 |
With that bit of an introduction, maybe I should
|
16 |
turn my attention now more directly to remedies. First,
|
17 |
I believe that in the software space at least, the
|
18 |
relevance of the antitrust law hangs on the issue of
|
19 |
remedies. I can think of no way as a practitioner and
|
20 |
an executive in a company in the industry to more
|
21 |
starkly illustrate that point than to disclose my actual
|
22 |
advice to my client in pursuing whether to participate
|
23 |
in or pursue any monopoly-related case, whether that be
|
24 |
in a government-related case or in private litigation.
|
25 |
I would tell my client, it's too expensive for |
36
1 |
you to fully embrace and do that. You cannot do it.
|
2 |
You don't have enough money to pursue it, it's certainly
|
3 |
over $10 million, it will be a long time, and it is
|
4 |
likely, I would submit to you, at least this would be my
|
5 |
advice, it is likely and substantially likely that the
|
6 |
remedy that will result will be of limited utility. So,
|
7 |
therefore, those sorts of expenditures would not be
|
8 |
justified.
|
9 |
And guess what? Those that the government
|
10 |
representatives seek to regulate know this, and they
|
11 |
know it well. By way of illustration, a high-ranking
|
12 |
representative, indeed a very high-ranking
|
13 |
representative of a party found to have market power by
|
14 |
multiple international competitive authorities has
|
15 |
aggressively and indeed smugly advised Red Hat that
|
16 |
there is no competition authority in the world that this
|
17 |
firm will not outspend, outlast, and seek to thwart.
|
18 |
In short, the system seems broken in terms of
|
19 |
speed, cost, and effectiveness of remedies, at least
|
20 |
from my little corner of the world. You know, why is
|
21 |
this the case? Well, as others have said, technological
|
22 |
change is very rapid and litigation is not. The rate of
|
23 |
change at least in information technology is in very
|
24 |
short cycles, three to five years, maybe six to eight
|
25 |
years, certainly not longer than that in many, many |
37
1 |
areas of information technology.
|
2 |
Remedies that only address a particular market
|
3 |
complained of, and established at great expense, will
|
4 |
often be too late to provide meaningful relief. A
|
5 |
remedy focused on future conduct would address some of
|
6 |
those limitations and in many instances I think is
|
7 |
necessary.
|
8 |
I also am intrigued by the idea of smaller
|
9 |
simpler cases with speedier trial times that would focus
|
10 |
on future contact to make the law more relevant.
|
11 |
Clearly cost and delay undermine the perceived and
|
12 |
actual effectiveness of the antitrust laws in our
|
13 |
competitive zone.
|
14 |
In that way, some of Professor's Lao's writing
|
15 |
on the role of the intent in finding liability seem a
|
16 |
fruitful avenue for further inquiry to me.
|
17 |
Second, technology can be manipulated. The
|
18 |
speed with which information technology moves and can be
|
19 |
molded provides real opportunity for conscious
|
20 |
manipulation by the monopolist away from the market
|
21 |
complained of. The government enforcement actions
|
22 |
against Microsoft are an example of the timing
|
23 |
challenges, I'm thinking now about the European Union,
|
24 |
even the most aggressive threats by the EC are mired in
|
25 |
delay, seemingly extended without limit. |
38
1 |
According to the most recent statistics we've
|
2 |
seen, Microsoft continues to gain in the operating
|
3 |
system worker group server market, meanwhile the market
|
4 |
continues its very rapid evolution, probably reducing
|
5 |
the relevance of any remedy that may eventually be
|
6 |
enforced and/or issued.
|
7 |
I guess I should also point out that private
|
8 |
enforcement actions have not solved the problem either,
|
9 |
this won't be a surprise from my earlier comment. The
|
10 |
antitrust law, like the Ritz Carlton, is open to the
|
11 |
rich and poor alike. The most entrepreneurial and the
|
12 |
most innovative firms, the small fledgling ones are
|
13 |
without means to mount private antitrust cases.
|
14 |
Let me turn my attention for a few moments to
|
15 |
innovation. Protecting competition does not mean
|
16 |
stifling innovation, I don't believe. While there is an
|
17 |
inevitable tension between the intellectual property law
|
18 |
and the antitrust law, competition law cannot achieve
|
19 |
its purpose if regulators and courts are preoccupied
|
20 |
with a concern that remedies affecting some intellectual
|
21 |
property rights will necessarily stifle innovation.
|
22 |
That focus on IP, that is intellectual property,
|
23 |
a legal concept, is misguided. The focus should be on
|
24 |
true innovation, not patents and copyrights, public
|
25 |
grants of a monopoly. |
39
1 |
Why is that the case? Well, first I think
|
2 |
equating innovation to the accumulation of intellectual
|
3 |
property is suspect, at least in the software world.
|
4 |
The software patent approach in the United States is
|
5 |
being broadly questioned, and that's the case for at
|
6 |
least two or three different reasons.
|
7 |
First of all, the software industry in
|
8 |
particular survived for almost 20 years with very
|
9 |
limited forms of software patents, not the broad range
|
10 |
that we now see following State Street and other court
|
11 |
decisions.
|
12 |
Second, I would submit to you the relationship
|
13 |
of software patents to innovation is suspect. I
|
14 |
regularly review the academic literature in this area
|
15 |
and I am aware of no convincing argument that software
|
16 |
patents have unleashed -- and no empirical study --
|
17 |
that they have unleashed and spurred additional
|
18 |
innovation.
|
19 |
Third, the news is regularly filled with stories
|
20 |
of highly suspect software patents, patents that are not
|
21 |
new and innovative, ones that are anticipated by prior
|
22 |
art and ones that common sense tell us lack sufficient
|
23 |
novelty to warrant 20 years of protection.
|
24 |
Of course that shouldn't be surprising, there
|
25 |
are well publicized challenges in the Patent & Trademark |
40
1 |
Office, there's no effective and searchable database on
|
2 |
prior art for software. There's also serious challenges
|
3 |
in retracting and retaining the kinds of experts that
|
4 |
Renata talked about to actually evaluate what is seeking
|
5 |
to be patented.
|
6 |
I say that just to suggest that the innovation
|
7 |
reflected in software patents is questionable at times.
|
8 |
Therefore, giving, you know, complete deference to
|
9 |
intellectual property in that context seems misguided.
|
10 |
Even more important to this debate, as my
|
11 |
opening remarks sought to illustrate, there are broad
|
12 |
communities of collaboration that are massively
|
13 |
innovative. Please note that their style of
|
14 |
collaboration is not readily or naturally susceptible to
|
15 |
patent protection, given the open and collaborative
|
16 |
nature of their exchanges.
|
17 |
Thus, innovation of the firm is not the only or
|
18 |
even the most effective form of innovation to be
|
19 |
considered or protected when facing the market
|
20 |
disruptive effects of monopolists. Powerful new
|
21 |
innovation paradigms are upon us now and they're growing
|
22 |
and they need to be considered and measured in balance.
|
23 |
But even if we were to assume that the firm is
|
24 |
the epicenter of innovation, the smallest and perhaps
|
25 |
most innovative are without the means to challenge the |
41
1 |
innovation of the monopolist that is purported to be
|
2 |
reflected in intellectual property. The combination of
|
3 |
suspect software patent quality and the disparity of the
|
4 |
cost to acquire a patent versus the cost to defend
|
5 |
against it skew IP protection in favor of larger
|
6 |
enterprises with market power.
|
7 |
Cost of acquiring a patent, let's say, is
|
8 |
$25,000 to $35,000. It absolutely pales in contrast to
|
9 |
the cost of a proper infringement defense. That is
|
10 |
variously $3 to $5 to $7 million, and by all accounts is
|
11 |
growing at present.
|
12 |
Moreover, the monopolist can disrupt the
|
13 |
business of smaller competitors merely by suggesting to
|
14 |
consumers that its IP is infringed, without any proof
|
15 |
whatsoever. If you consider Steven Bommer's recent
|
16 |
statements that the users of Linux have an undisclosed
|
17 |
off balance sheet liability to Microsoft, which were
|
18 |
offered without any substantiation whatsoever. And the
|
19 |
SCO litigation that is ongoing I think offers some
|
20 |
interesting and vicarious variance on the same theme,
|
21 |
which I would also be happy to comment on in the
|
22 |
question and answer period.
|
23 |
Keeping on the intellectual property theme, an
|
24 |
effective remedy needs to prevent the extension of
|
25 |
market power. A company who has acquired market power |
42
1 |
through anticompetitive conduct shall not be permitted
|
2 |
to be able to hide behind intellectual property
|
3 |
protection to reinforce and extend its market power. I
|
4 |
think there is an interesting lesson in history on this
|
5 |
that deals with data formats.
|
6 |
In particular, I would like to contrast how
|
7 |
Microsoft came to compete in word processing, versus how
|
8 |
it now competes. The background is as follows:
|
9 |
Software products manipulate and ultimately store
|
10 |
customer data after that manipulation. To the extent
|
11 |
this data is then placed into storage formats, that are
|
12 |
claimed as either proprietary or protected by
|
13 |
intellectual property of the software vendor, then the
|
14 |
ability of a competing product to make effective use of
|
15 |
the stored customer data and break into and compete in
|
16 |
that market, which is likely reinforced by very strong
|
17 |
network effects, can be precluded.
|
18 |
Take, for example, Microsoft's word processor
|
19 |
competition against the then-important market position
|
20 |
of the WordPerfect product in the 1980s. Because the
|
21 |
data format's inability to represent the data with
|
22 |
substantial fidelity was possible, Microsoft could
|
23 |
compete at the enterprise level by saying, give me a try
|
24 |
in parallel with WordPerfect. If I do better, then
|
25 |
incur the cost of switching out your old technology and |
43
1 |
taking on our technology.
|
2 |
In contrast today, I would submit to you the
|
3 |
formats of Microsoft alphus data have been and are
|
4 |
increasingly being obscured by Microsoft and cannot be
|
5 |
presented, that is the data cannot be presented with
|
6 |
true fidelity by any competitor, like OpenOffice, which
|
7 |
thereby extends the time of their dominant position and
|
8 |
permits extension of power into adjacent markets.
|
9 |
It is the case that Red Hat cannot effectively
|
10 |
compete with open source personal productivity
|
11 |
applications, like word processors and other things, at
|
12 |
the enterprise level against Microsoft, it can't get its
|
13 |
foot in the door. If a client wants to give someone a
|
14 |
try and you can't render their existing data in a
|
15 |
meaningful fashion, that prevents anyone from entering
|
16 |
into that market, I would submit to you, or doing so
|
17 |
easily, anyway.
|
18 |
Microsoft controls, I would submit to you, a
|
19 |
facility of competition through the extension of IP and
|
20 |
proprietary formats that is needed to meaningfully
|
21 |
render and manipulate customer data. I have no doubt
|
22 |
that's why you're seeing states like Massachusetts
|
23 |
aggressively consider the open document format, a truly
|
24 |
open standard in format in its procurement processes.
|
25 |
The mono type litigation of Red Hat is another |
44
1 |
example that illustrates that that I would be happy to
|
2 |
comment on later.
|
3 |
In summary, I guess I would say that innovation
|
4 |
does not equate to intellectual property, and therefore
|
5 |
greater focus on preserving and promoting true
|
6 |
innovation in the marketplace is warranted. Further,
|
7 |
there are numerous ways in which the use and assertion
|
8 |
of intellectual property rights can be a pretext that
|
9 |
chills competition and extends monopoly power.
|
10 |
Thank you.
|
11 |
(Applause.)
|
12 |
MR. HILLEBOE: Thank you very much, Michael, for
|
13 |
that, and I think we will take about a ten-minute break
|
14 |
now.
|
15 |
(Whereupon, there was a recess in the
|
16 |
proceedings.)
|
17 |
MR. HILLEBOE: Thank you, everyone. William
|
18 |
Page is a Marshall M. Criser eminent scholar at the
|
19 |
University of Florida Levin College of Law and he is
|
20 |
also an alumnus of the Antitrust Division, where he
|
21 |
served as a trial attorney in the 1970s.
|
22 |
Bill?
|
23 |
MR. PAGE: Thank you. Rather than speak in
|
24 |
generalities about Section 2 remedies in high-tech
|
25 |
markets, I want to zero in on one highly technical and |
45
1 |
seemingly obscure provision in the final judgments in
|
2 |
the government's Microsoft case that has turned out to
|
3 |
be the most difficult and the most problematic in its
|
4 |
enforcement.
|
5 |
The provision requires Microsoft to license to
|
6 |
software developers communications protocols that
|
7 |
Microsoft uses in its Windows Client operating systems
|
8 |
to interoperate with Microsoft server operating systems,
|
9 |
either in corporate networks or over the Internet.
|
10 |
Communications protocols are the rules for transmitting
|
11 |
information between different devices.
|
12 |
So, in a computer network, the protocols allow a
|
13 |
user of a client computer, for example, to store
|
14 |
information on a network drive or send an email or
|
15 |
display a web page, among many other things.
|
16 |
This sort of interoperation is relatively easy
|
17 |
when the client computer's operating system and the
|
18 |
server operating system share a common base in code.
|
19 |
It's like they speak the same language, so they can
|
20 |
interoperate easily.
|
21 |
Where the client computer, usually a Windows
|
22 |
client, has to interoperate with servers from other
|
23 |
vendors, then the problem with interoperability becomes
|
24 |
much more difficult, but there are ways of solving them.
|
25 |
There are recognized ways of solving them. Some involve |
46
1 |
installing a client on Windows that would allow
|
2 |
interoperation with the non-Windows server and
|
3 |
applications running on it.
|
4 |
There are also standard protocols that are
|
5 |
available and supported in Windows. This provision
|
6 |
requires another way of assuring interoperation, that is
|
7 |
requires Microsoft to disclose its proprietary
|
8 |
protocols, to license them to software developers so
|
9 |
that they can interoperate. The near-term goal would be
|
10 |
for them to be able to write programs that will
|
11 |
interoperate as well with Windows clients as
|
12 |
applications running on Microsoft servers.
|
13 |
The long-term goal is to allow -- is to preserve
|
14 |
in this network context the so-called middleware threat
|
15 |
that was the focus of the government case. The
|
16 |
middleware applications running on servers, the concern
|
17 |
is, may eventually evolve into platforms that could
|
18 |
rival the Windows desktop and thereby erode the
|
19 |
application's barrier to entry. Essentially the theory
|
20 |
of the government case.
|
21 |
In spite of its apparent obscurity, this
|
22 |
provision has been given an unusual amount of importance
|
23 |
by the District Court enforcing the Microsoft judgment.
|
24 |
She's referred to it as the most forward looking
|
25 |
provision in the final judgments and as necessary to |
47
1 |
assure that the other provisions don't become
|
2 |
prematurely obsolete. It's now being implemented by the
|
3 |
two sets of plaintiffs in the Microsoft litigation, the
|
4 |
Antitrust Division and the nine settling states, and
|
5 |
also by the group of non-settling plaintiffs who were
|
6 |
awarded essentially the same relief, but there are
|
7 |
different enforcement mechanisms.
|
8 |
There's the technical committee that Renata
|
9 |
referred to in the Antitrust Divisions's consent decree
|
10 |
and there's a technical consultant to the non-settling
|
11 |
states under their decree, but they're coordinating
|
12 |
their enforcement efforts. Both of these judgments went
|
13 |
into effect in 2002.
|
14 |
And the plaintiffs in both cases and Microsoft
|
15 |
has been filing status reports every two months about
|
16 |
the enforcement of both of the judgments, and I have
|
17 |
studied these reports with the help of a research
|
18 |
assistant, who was also a software developer and a
|
19 |
management consultant, and so he has been sort of my
|
20 |
technical consultant. He provided all of the technical
|
21 |
expertise in this study, because I certainly claim none.
|
22 |
The enforcement of this provision, this one
|
23 |
provision in these judgments has dominated these
|
24 |
reports, particularly in recent years. It by far
|
25 |
occupies most of the reports and certainly most of the |
48
1 |
time of the technical committee. And I'll argue that
|
2 |
this provision has not accomplished its purpose, and
|
3 |
that we can draw some lessons from that experience.
|
4 |
So, I want to first describe what I take to be
|
5 |
the principles of Section 2 remedies, I'll then suggest
|
6 |
that most of the provisions in the Microsoft judgments
|
7 |
adhere to these principles, but that this provision, the
|
8 |
protocol licensing provision, departs from the
|
9 |
principles and that is part of the reason why it has not
|
10 |
been successful.
|
11 |
I'll describe briefly how it has been
|
12 |
implemented and then in the end I'll try to draw some
|
13 |
lessons. And incidentally, this is a very brief summary
|
14 |
of a much longer article which I hope to post on SSRN
|
15 |
shortly.
|
16 |
The goals of Section 2 remedies should be to
|
17 |
restore competitive conditions that would have existed
|
18 |
but for the illegal conduct. They should not be to try
|
19 |
to restore or to create some sort of ideal competitive
|
20 |
condition or to supervise market outcomes. I take the
|
21 |
primary antitrust remedy to be deterrence, through fines
|
22 |
and covered damages. If deterrence can be effective, if
|
23 |
an optimal penalty can be imposed, that's always going
|
24 |
to be preferable to having an administrative structure
|
25 |
imposing remedies. It's simply the direct costs of |
49
1 |
imposing those remedies will be -- will impose a greater
|
2 |
cost than effective deterrence.
|
3 |
Assuming that some sort of injunctive relief is
|
4 |
required, I would suggest that injunctions should be
|
5 |
limited to preventing reoccurrence of proven
|
6 |
anticompetitive behavior. The Sherman Act, unlike
|
7 |
sector-specific regulation, I believe reflects the
|
8 |
assumption that if specific impediments to competition
|
9 |
are removed, then private contracting within the market
|
10 |
will lead to the efficient outcome. And if that would
|
11 |
not be the case, then that would argue that the market
|
12 |
should be regulated.
|
13 |
Beyond that, I would suggest that injunctions
|
14 |
are problematic. First, divestiture, at least in the
|
15 |
case of a unitary company, should be a last resort,
|
16 |
primarily appropriate to dissolve recent combinations.
|
17 |
Regulatory decrees also, as many have observed, should
|
18 |
be avoided. As the Supreme Court said in Trinko, they
|
19 |
require antitrust courts to act as central planners,
|
20 |
identify improper price policy and other terms of
|
21 |
dealing in roles for which they are well suited.
|
22 |
Most of the Microsoft final judgment provisions
|
23 |
reflect these principles. They do not require any form
|
24 |
of divestiture, and most provisions respond more or less
|
25 |
directly to the liability holdings in the case that were |
50
1 |
affirmed by the D.C. Circuit in 2001, prohibiting
|
2 |
retaliation against computer manufacturers for promoting
|
3 |
rival software, requiring uniform licensing terms,
|
4 |
giving computer manufacturers the flexibility to remove
|
5 |
the visible means of access to Microsoft middleware
|
6 |
products and so forth.
|
7 |
The protocol licensing provision does not
|
8 |
respond directly to any illegal conduct. Server-based
|
9 |
applications were mentioned in the findings of fact,
|
10 |
only to exclude them from the market.
|
11 |
Interoperability in networks was not an issue in
|
12 |
the case, and in fact developing and refusing to license
|
13 |
incompatible proprietary software was not held illegal,
|
14 |
in fact, it was specifically held to be legal, if
|
15 |
nothing more than that were shown.
|
16 |
So, where did this come from? The idea for this
|
17 |
provision actually arose, according to Ken Alletta's
|
18 |
book on the Microsoft litigation, after the findings of
|
19 |
fact had been issued. In other words, after the record
|
20 |
was closed in the case. The feeling was that Microsoft
|
21 |
essentially was not going to continue the conduct that
|
22 |
was actually the subject of the litigation, the browser
|
23 |
wars were over, Microsoft had already stopped the
|
24 |
discriminatory pricing, it had gotten rid of the
|
25 |
exclusive terms in its contracts, so we needed to be |
51
1 |
more forward looking and what was forward was this
|
2 |
network environment.
|
3 |
The fear was that in this -- you've got to, you
|
4 |
know, as the computer market moved toward networks, both
|
5 |
local corporate networks and the Internet, it was
|
6 |
necessary to assure that Microsoft would not
|
7 |
discriminate in allowing rivals to interoperate with the
|
8 |
dominant Windows client.
|
9 |
And, so, various proposals for various
|
10 |
interfaces by Microsoft were made. After the original
|
11 |
judgment was reversed, of course the Antitrust Division
|
12 |
reached an agreement with Microsoft on the consent
|
13 |
decree and it included a version of this. The protocol
|
14 |
licensing provision, which essentially we now have, in
|
15 |
both that consent decree and in this -- the states'
|
16 |
judgment.
|
17 |
Judge Kollar-Kotelly approved this provision,
|
18 |
even though she recognized that the government was not
|
19 |
strictly entitled to it, because it was not responsive
|
20 |
to proven illegality, and she also recognized that there
|
21 |
were these other ways in networks of achieving
|
22 |
interoperability besides requiring Microsoft to license
|
23 |
its proprietary protocols.
|
24 |
Nevertheless, she found that -- and here's the
|
25 |
key language, it's closely connected to the theory of |
52
1 |
liability in this case, and furthers efforts to prevent
|
2 |
future monopolization.
|
3 |
So, under this program, Microsoft has developed
|
4 |
the Microsoft communications protocol program, which is
|
5 |
an extension of its Microsoft developers network, and
|
6 |
under this program, it offers a license to these
|
7 |
protocols, and technical documentation. In the initial
|
8 |
response in August 2002, actually before the consent
|
9 |
decree was approved, but nine months after it was
|
10 |
originally agreed to by the parties, Microsoft produced
|
11 |
5,000 pages of technical information, documentation, on
|
12 |
the protocols, which it reported with a product of the
|
13 |
work of five technical writers working essentially
|
14 |
full-time for nine months.
|
15 |
By July 2003, however, eight months after the
|
16 |
entry of the final judgments, only four developers had
|
17 |
licensed these protocols. And Judge Kollar-Kotelly told
|
18 |
the parties in a status conference, this is reported in
|
19 |
the report, that she was very, very concerned that
|
20 |
nobody was taking these licenses. And both Microsoft
|
21 |
and the government responded to this by various efforts
|
22 |
to promote them. Microsoft took out ads, they
|
23 |
evangelized these protocols, but with very little
|
24 |
success. And finally the government conducted a survey
|
25 |
of developers asking them why aren't you licensing this |
53
1 |
material, and they gave a list of reasons, some of which
|
2 |
focused on the license itself, said it was way too
|
3 |
complicated, it was pages of technical terms, and they
|
4 |
were too expensive, the technical documentation was
|
5 |
insufficient, the royalty was too high, whatever. But
|
6 |
some said, we just don't need them for our development
|
7 |
efforts.
|
8 |
All of these, except that last one, were
|
9 |
addressed over the next three years. The license term
|
10 |
has been extended, the limitations in it have been
|
11 |
relaxed, and simplified, the royalties have been
|
12 |
reduced, many of the open standard protocols that
|
13 |
Microsoft supports have been made available under the
|
14 |
royalty free license. Microsoft has made its source
|
15 |
code available to licensees.
|
16 |
Now, to become a licensee, you need to show you
|
17 |
have a legitimate purpose. So, you can't go and ask to
|
18 |
see the source code, but if you are a licensee and you
|
19 |
can show that you have need for it, under the license,
|
20 |
then they'll show it to you and they'll actually provide
|
21 |
support to show you how to use it. It's also provided
|
22 |
500 hours of free premier technical support, it's
|
23 |
provided a dedicated account manager, it's provided
|
24 |
three-day, what they call plug fests, where you can
|
25 |
bring your product and test it and Microsoft engineers |
54
1 |
will work with you to try to make sure it interoperates
|
2 |
well with Windows. It's created an interoperability
|
3 |
lab, and I should mention, when we had the first plug
|
4 |
fest, only two licensees signed up for it, no one has so
|
5 |
far signed up for the interoperability lab.
|
6 |
So, over the years, what's most dramatic about
|
7 |
these status reports is the accounts of how Microsoft
|
8 |
and the technical committee have tried to improve the
|
9 |
technical documentation of the protocols.
|
10 |
In July 2004, the technical committee and
|
11 |
Microsoft agreed on a 40-page specification that the
|
12 |
documentation was supposed to meet. And the technical
|
13 |
committee undertook to develop what it calls prototype
|
14 |
implementations of each protocol. There are about 100
|
15 |
and 120 protocols, and in order to assure that the
|
16 |
documentation of them was sufficient, the technical
|
17 |
committee has undertaken to try to actually write a
|
18 |
little application using the protocol.
|
19 |
And, so, if they could do that, then that would
|
20 |
show that the documentation, it could actually be put
|
21 |
into effect by the developer. Where they run into
|
22 |
problems, if they ran into problems, they treated that
|
23 |
as an issue, and they reported that to Microsoft as a
|
24 |
bug to be addressed, and depending on its importance,
|
25 |
they gave them seven days or, you know, longer time |
55
1 |
limits to respond to it.
|
2 |
And this was the approach for about a year, but
|
3 |
by early 2006, the technical committee had reported to
|
4 |
Microsoft about a thousand of these issues, and only
|
5 |
about 300 of them -- 300 of them had been resolved, and
|
6 |
in May, this is about a year ago, the plaintiffs
|
7 |
reported to the judge that the project had reached what
|
8 |
it called a watershed, and at that point, someone who I
|
9 |
take to be a strong personality, Robert Muglia, who is
|
10 |
the senior vice president of Microsoft and formerly was
|
11 |
the head of server division, reviewed this program and
|
12 |
said that this process of trying to respond to bugs one
|
13 |
by one, as they're reported by the technical committee,
|
14 |
was just not working, and that we would need to start
|
15 |
from scratch and rewrite all of the technical
|
16 |
documentation.
|
17 |
And, so, last summer, incidentally, it was at
|
18 |
this point that the technical committee made contact
|
19 |
with the European Commission's monitoring trustee, which
|
20 |
is also administering an order to Microsoft to disclose
|
21 |
protocols, and in connection with those communications
|
22 |
had with Microsoft, agreed on a new overarching
|
23 |
specification. This is now the third standard that will
|
24 |
be used to judge the documentation.
|
25 |
And Microsoft was given a new set of milestones, |
56
1 |
time tables, to complete the project. At this point, it
|
2 |
was clear that the decrees were due to expire in the
|
3 |
fall, and it was pretty clear that that was not going to
|
4 |
be enough time to do all of this, and so that's when the
|
5 |
parties agreed to extend the term of the judgment for up
|
6 |
to five years.
|
7 |
Meanwhile, Microsoft has suspended royalty
|
8 |
payments entirely for its licensees, until the
|
9 |
documentation is deemed to be sufficient, and the
|
10 |
technical committee has continued to develop these
|
11 |
protocol implementations, and interestingly, Microsoft
|
12 |
has also undertaken to do something similar, developing
|
13 |
what they call test suites, which it's one of the
|
14 |
practices of software developers when they're working on
|
15 |
an application, they come up with suites of testing
|
16 |
applications to see if they work, and Microsoft has
|
17 |
undertaken sort of a parallel or duplicate testing
|
18 |
mechanism.
|
19 |
And in this most recent status report, which was
|
20 |
issued earlier this month, the plaintiffs reported that
|
21 |
although they've had some questions about Microsoft --
|
22 |
apparently Microsoft discovered some new protocols that
|
23 |
they hadn't identified before, they said that this new
|
24 |
documentation is looking better, although significant
|
25 |
additional work needed to be done. |
57
1 |
So, Microsoft now has been -- remember the first
|
2 |
project, it had a few technical writers working for a
|
3 |
certain number of months to produce these 5,000 pages.
|
4 |
They now have 313 employees working on this project.
|
5 |
And the technical committee also has increased its staff
|
6 |
to 40 engineers, and they now have offices both in
|
7 |
Redmond, Washington and in Silicon Valley.
|
8 |
The bottom line, as of this month's status
|
9 |
report, of the thousands of developers writing
|
10 |
applications for servers, for server operators, to run
|
11 |
on server operating systems, only 27 firms have taken
|
12 |
the royalty-based license, and all but four of these,
|
13 |
but for very specific purposes, like media streaming or
|
14 |
data storage or security, the proxy firewall segment.
|
15 |
So, and of those 27, only 14 are producing any products.
|
16 |
And none of these products seems likely to have any
|
17 |
potential as a platform.
|
18 |
So, what are the lessons from this experience?
|
19 |
The original rationale for this project was to preserve
|
20 |
the middleware threat to the Microsoft monopoly in the
|
21 |
network environment. If so, at least so far, the
|
22 |
project has not succeeded, because it's attracted very
|
23 |
few licensees, despite these enormous efforts, and I
|
24 |
think quite admirable, and impressive efforts on both
|
25 |
sides. |
58
1 |
What this suggests to me is that the primary
|
2 |
reason why we're not seeing more licensees is that
|
3 |
licensing Microsoft's proprietary protocols is generally
|
4 |
not necessary for these firms to develop software
|
5 |
applications to run on non-Microsoft servers. They can
|
6 |
use the standard protocols that Microsoft supports in
|
7 |
Windows, or they can develop their own windows client
|
8 |
which then could run on the Windows client and
|
9 |
communicate directly through Microsoft's application
|
10 |
programming interfaces.
|
11 |
So, to boil it down, what I would say is that
|
12 |
what this remedy does is to treat the Microsoft
|
13 |
protocols as if they were an essential facility, except
|
14 |
that they're not essential. There are other ways of
|
15 |
accomplishing the same thing.
|
16 |
So, what I would take to be the two primary
|
17 |
lessons are first, injunctive relief, particularly in
|
18 |
high technology markets, should be limited to responding
|
19 |
to a proven need, and the most important proven need is
|
20 |
to -- is to interdict and remove anticompetitive
|
21 |
practices, proven anticompetitive practices.
|
22 |
So, if Microsoft is proven to have engaged in
|
23 |
practices that violate the antitrust laws, those should
|
24 |
be enjoined. But as we've seen, the protocol licensing
|
25 |
provision did not respond to a proven violation, and did |
59
1 |
not even address technology -- and it addressed
|
2 |
technologies that were not even the focus of the
|
3 |
liability phase.
|
4 |
During the remedial proceedings, there was a
|
5 |
record developed on network computing and there was
|
6 |
evidence introduced of various so-called bad acts, as
|
7 |
Judge Kollar-Kotelly characterized them, but she treated
|
8 |
them as being essentially irrelevant, because they had
|
9 |
not been shown to be anticompetitive, or at least if
|
10 |
they were anticompetitive, they may have had
|
11 |
pro-competitive justifications that had not been
|
12 |
considered.
|
13 |
The second, under this heading of only
|
14 |
responding to a proven need, I don't want to rule out
|
15 |
the possibility that forward-looking or fencing in kinds
|
16 |
of provisions may be necessary, but if they are, then I
|
17 |
think there should be -- there should be a record built
|
18 |
to support the need for them. And I think in this case,
|
19 |
for example, we know that the government at one point
|
20 |
actually surveyed software developers to see what their
|
21 |
needs were in this area.
|
22 |
I'm not sure what was done during the
|
23 |
negotiation of the consent decree, but perhaps more in
|
24 |
that direction could have been done to find out
|
25 |
precisely what was needed to ensure adequate |
60
1 |
interoperation.
|
2 |
And also I would just add that the Court of
|
3 |
Appeals in the 2001 decision cautioned that remedies
|
4 |
should be proportional to the strength of the proof that
|
5 |
Microsoft's illegal actions actually reduced
|
6 |
competition, and that was why the Court of Appeals said
|
7 |
that divestiture was probably not going to be an
|
8 |
appropriate remedy, because as they put it, the harm to
|
9 |
competition for Microsoft's actions, in other words,
|
10 |
whether they had actually prevented Netscape's browser
|
11 |
or Java from evolving into a rival platform, that was
|
12 |
established by only -- as they put it -- by inference,
|
13 |
in other words, there was no evidence that that actually
|
14 |
would have happened. And where you have that relatively
|
15 |
weak evidence of likely anticompetitive effect, then you
|
16 |
need more evidence to support more Draconian remedies.
|
17 |
And divestiture is certainly that, but I also
|
18 |
think regulatory relief is also a Draconian remedy, and
|
19 |
that brings me to my second lesson, and that is to avoid
|
20 |
regulatory decrees, especially in high technology
|
21 |
markets. And this was recognized, Judge Kolar-Kotelly
|
22 |
rejected one principle during the remedial proceedings,
|
23 |
on the grounds that it would result in too regulatory of
|
24 |
a decree.
|
25 |
Well, the protocol licensing has become highly |
61
1 |
regulatory and direct government supervision of price
|
2 |
and other terms of dealing and especially quality.
|
3 |
Direct government supervision of quality that's being
|
4 |
produced. And the device of the technical committee
|
5 |
certainly has provided a high level of expertise, but in
|
6 |
effect, what its created is a regulatory body, and I'm
|
7 |
not sure that the structure of the technical committee
|
8 |
and its relationship to the plaintiffs and the court
|
9 |
establishes an effective regulatory agency.
|
10 |
So, just to conclude, if in the future cases
|
11 |
have these characteristics, those should be treated as
|
12 |
warning signs, and addressed in the -- in the relief.
|
13 |
And with that I'll sit down.
|
14 |
(Applause.)
|
15 |
MR. HILLEBOE: Thank you, Bill. Marina Lao is a
|
16 |
professor of law at Seton Hall Law School. She
|
17 |
currently serves on the executive board of the section
|
18 |
on antitrust law of the American Association of Law
|
19 |
Schools, and she's an alumna of the Antitrust Division,
|
20 |
where she was a trial attorney. She has published
|
21 |
numerous articles on antitrust law and trade regulation,
|
22 |
and somewhat surprisingly on this high-tech panel, she
|
23 |
is the only speaker with slides.
|
24 |
Marina?
|
25 |
MS. LAO: I guess it's even more surprising |
62
1 |
given that I am usually the least high-tech person on
|
2 |
the panel. Thank you very much for inviting me and I'm
|
3 |
happy to have the opportunity to participate in this
|
4 |
hearing.
|
5 |
I agree with a number of the speakers who have
|
6 |
gone before me who have said that remedies are often
|
7 |
treated as an after thought. Unfortunately, that's not
|
8 |
a very good idea, because success in proving liability
|
9 |
often does not translate into success in remedying the
|
10 |
anticompetitive situation, and so it's often best to
|
11 |
work your vision of remedy into the case development
|
12 |
much earlier on.
|
13 |
What I'm going to do, since I'm bringing up the
|
14 |
rear, is to try not to overlap too much with what has
|
15 |
been said; I'm going to focus on three main points in my
|
16 |
comments and I will be skipping over some of the slides.
|
17 |
First, where network effects are substantial in
|
18 |
the industry that's affected by Section 2 violation, I
|
19 |
probably differ from Bill, in that I think that there's
|
20 |
a need for broader rather than narrower remedies for
|
21 |
some of the reasons that I'll talk about later.
|
22 |
Second, again, I guess on this issue I differ a
|
23 |
bit from Bill as well. I'm going to talk about the
|
24 |
importance of forward-looking remedies. I would call
|
25 |
them affirmative remedies that reduce rivals' costs and |
63
1 |
some of the problems in crafting them. I do agree that
|
2 |
tayloring these remedies to the problem is a bit
|
3 |
difficult.
|
4 |
And lastly, I'm going to discuss whether there's
|
5 |
any value in bringing Section 2 enforcement action if
|
6 |
there is no effective judicial remedy. My conclusion is
|
7 |
that there is deterrent value to bringing an enforcement
|
8 |
action, even if it is irremediable, so to speak.
|
9 |
Let me start with a few words about the ongoing
|
10 |
debate among antitrust commentators on the application
|
11 |
of antitrust in the dynamic high technology markets.
|
12 |
The question that is often raised is: Do we need more
|
13 |
rigorous antitrust enforcement or do we need a more
|
14 |
hands-off approach? Those who say that less
|
15 |
intervention is necessary generally argue that because
|
16 |
there is rapid innovation, product cycles are short, and
|
17 |
so dominance is fleeting. And there are continuous
|
18 |
opportunities for fringe firms to overtake the
|
19 |
incumbent. The Microsofts of the world will have to
|
20 |
constantly innovate or they're going to be left in the
|
21 |
dust.
|
22 |
And so for that reason, there's really not that
|
23 |
much of a need for antitrust intervention in order for
|
24 |
markets to remain robust. In fact, too much antitrust
|
25 |
intervention could stifle innovation and competition. |
64
1 |
While there's obviously some truth to that
|
2 |
argument, I think the Microsoft case itself tells us
|
3 |
that rapid technological change can cut the other way,
|
4 |
especially when you have substantial network effects
|
5 |
which tend to operate as significant barriers to entry.
|
6 |
If these are substantial network barriers to entry, a
|
7 |
clearly dominant firm can much more easily exclude even
|
8 |
superior technologies, up to only a certain point, of
|
9 |
course, if it can ensure that the rival technologies
|
10 |
remain incompatible.
|
11 |
And, the dominant firm can also control research
|
12 |
avenues, up to a certain point. What's more, even
|
13 |
without any antitrust violations, there are natural
|
14 |
benefits, that flow from network effects of those
|
15 |
natural benefits, I think dominant firms can more easily
|
16 |
use tying and other exclusionary strategies to preserve
|
17 |
their dominance and to exclude competitors
|
18 |
anticompetitively.
|
19 |
So, my conclusion is that antitrust intervention
|
20 |
is not only not redundant, but there is perhaps an even
|
21 |
stronger need for it when you have markets with strong
|
22 |
network effects.
|
23 |
With respect to remedies, there's a similar
|
24 |
ongoing debate among commentators. There are those who
|
25 |
say that with fast moving technologies, you need milder |
65
1 |
remedies, remedies that are less severe, because of
|
2 |
several reasons. First, there is the self correcting
|
3 |
market rationale, which postulates that the market is
|
4 |
going to correct itself much faster than antitrust
|
5 |
intervention can correct it. Second, advocates of mild
|
6 |
remedies warn of the possibility of unintended
|
7 |
consequences, that is where market conditions in the
|
8 |
future are uncertain, one may not know what to prohibit
|
9 |
and what not to prohibit, and so the remedies adopted
|
10 |
today may not be sensible a few years hence.
|
11 |
And, so, they argue it is probably safer to
|
12 |
adopt milder forms of remedy in order to lessen the risk
|
13 |
of chilling innovation and competition from the dominant
|
14 |
firm.
|
15 |
First of all, I happen to think that high-tech
|
16 |
markets do not that easily, at least self correct, not
|
17 |
if network externalities exist, because by definition, a
|
18 |
self correcting market, requires innovation and new
|
19 |
entry, but network effects raise entry barriers and
|
20 |
reduce access to the network.
|
21 |
Obviously easy entry markets are not going to
|
22 |
easily self correct.
|
23 |
As to the argument that uncertainty about future
|
24 |
market conditions means that we should perhaps take a
|
25 |
more hands-off approach and apply the mildest remedy |
66
1 |
possible, I also do not completely agree with that. I
|
2 |
think that if market conditions are uncertain, we have
|
3 |
to exercise more care in defining the future boundaries
|
4 |
of the relevant market, and in identifying the
|
5 |
participants in this future market, and in crafting the
|
6 |
remedy.
|
7 |
But we should not overlook the danger of doing
|
8 |
too little too late, which carries its own risk as well.
|
9 |
Another possible solution to the uncertain market
|
10 |
condition problem is to have a continuing jurisdiction
|
11 |
clause in the remedial order, which I know is not a
|
12 |
common practice. With a continuing jurisdiction clause
|
13 |
either party can go back to the court for modification
|
14 |
if it turns out that the remedies agreed upon do not
|
15 |
work because of changing market conditions.
|
16 |
As to the "potential chilling effects" argument,
|
17 |
it's often said by advocates of milder remedies that
|
18 |
compulsory licenses of IP rights and other affirmative
|
19 |
remedies tend to chill innovation on the part of the
|
20 |
dominant firm, that's basically one of the points
|
21 |
Justice Scalia made in Trinko.
|
22 |
What is often lost in this discussion, though,
|
23 |
is that competition and innovation from fringe firms are
|
24 |
also very important, and if remedies for an antitrust
|
25 |
violation are insufficient, innovation and competition |
67
1 |
from fringe firms could be chilled. The AT&T
|
2 |
divestiture experience is very instructive. Few would
|
3 |
disagree that the structural remedy in the AT&T case
|
4 |
unleashed innovation from smaller telecommunications
|
5 |
firms on an unprecedented scale, which enhanced consumer
|
6 |
welfare.
|
7 |
Another point that we should not lose sight of
|
8 |
is that with high technology markets, it's extremely
|
9 |
difficult to resuscitate a competitor, after the
|
10 |
competitor has been crushed. The convergence of factors
|
11 |
that produced a competitive challenge before it was
|
12 |
anticompetitively excluded, may never re-appear, not in
|
13 |
the same fashion, anyway.
|
14 |
The factors together call for a solution that is
|
15 |
less hands-off.
|
16 |
They also lead me to conclude that narrowly
|
17 |
focusing the remedy on the specific conduct found to be
|
18 |
unlawful, will not return competition to the status quo;
|
19 |
thus drafting or crafting forward-looking remedies is
|
20 |
quite important.
|
21 |
Of course I do realize that forward-looking
|
22 |
remedies have to be carefully tailored.
|
23 |
The problem one faces in crafting
|
24 |
forward-looking remedies is that you have to understand
|
25 |
the market. You've got to analyze the likely evolution |
68
1 |
of the market, predict which way the market is headed,
|
2 |
the innovations will likely emerge, what will be the
|
3 |
next generation of innovations, and how these
|
4 |
innovations might change the path of the market.
|
5 |
Unless you have a pretty good grip on these
|
6 |
issues, it's very difficult to predict what remedial
|
7 |
actions would work to break down entry barriers and
|
8 |
facilitate competition, and what would not.
|
9 |
If we do not know what is going to work, then we
|
10 |
risk adopting an injunction that constrains conduct that
|
11 |
no longer needs to be constrained, but does not
|
12 |
constrain conduct that needs to be constrained. Perhaps
|
13 |
the prime example of this is the first Microsoft consent
|
14 |
decree, which prohibited Microsoft from "per processor"
|
15 |
licensing which it had engaged in. But by the time of
|
16 |
the decree, Microsoft no longer needed to engage in that
|
17 |
strategy, because its competitors in the operating
|
18 |
systems market were already defunct and the prohibition
|
19 |
accomplished nothing.
|
20 |
Another problem, I think, that is rather
|
21 |
peculiar to high-tech markets is having to anticipate
|
22 |
how dominant firms might circumvent the judicial
|
23 |
constraints imposed and still achieve their
|
24 |
anticompetitive ends, and then block these alternative
|
25 |
paths in the in the decree as well. Fast-changing |
69
1 |
markets tend to be pretty malleable, thus giving the
|
2 |
dominant firm myriad ways to achieve its anticompetitive
|
3 |
objective.
|
4 |
To understand how Microsoft or any dominant firm
|
5 |
might sidestep an injunction and still achieve its end,
|
6 |
we need to know what the possible alternative strategies
|
7 |
are. But dominant firms generally have an information
|
8 |
asymmetries advantage over the government that's quite
|
9 |
natural.
|
10 |
That is, the government knows much less than the
|
11 |
dominant firm about what the potential new innovations
|
12 |
and the possible alternative strategies to achieving the
|
13 |
anticompetitive objective are. So how can the
|
14 |
government overcome the information asymmetries problem?
|
15 |
I think the simplest solution is to just enlist the
|
16 |
assistance of the dominant firm's competitors or
|
17 |
potential competitors, who probably are in a much better
|
18 |
position than any outsider, including government
|
19 |
enforcers, to know about the industry, to know what
|
20 |
remedies might work and what might not work, and what is
|
21 |
the innovation trend, et cetera.
|
22 |
Oftentimes, when this is mentioned as a possible
|
23 |
solution, you hear the argument that, well, then, the
|
24 |
department or agency might be subject to capture. I
|
25 |
think that simply relying on competitors to educate |
70
1 |
government enforcers on the market is not equivalent to
|
2 |
capture, and is also entirely consistent with the
|
3 |
principle that we should protect competition and not
|
4 |
competitors.
|
5 |
Let me turn, briefly, to the importance of
|
6 |
implementing creative affirmative obligations. The
|
7 |
problem with conduct remedies and I'm not discussing
|
8 |
structural remedies at all, because it's been discussed
|
9 |
in detail already is that generally speaking, if the
|
10 |
dominant firm has already successfully excluded its
|
11 |
competitor and potential competitors, simply stopping
|
12 |
the conduct and preventing its recurrence is not going
|
13 |
to be enough to restore competition. That is because
|
14 |
stopping the exclusionary conduct will not unravel the
|
15 |
dominant firm's accumulated market power.
|
16 |
Instead, what would be helpful would be to
|
17 |
impose affirmative duties on the dominant firm. I call
|
18 |
it lowering rivals' cost as opposed to raising rivals'
|
19 |
cost. The Post-Chicago school has said that dominant
|
20 |
firms can exclude competition anticompetitively by
|
21 |
engaging in strategies that raise rivals' costs. For
|
22 |
remedy purposes, we need to go a little bit beyond
|
23 |
prohibiting acts that raise rivals' costs; we need to
|
24 |
impose some obligation on the part of the dominant firm
|
25 |
to reduce rivals' costs. |
71
1 |
Some affirmative duties are pretty well
|
2 |
established in antitrust jurisprudence, and are not very
|
3 |
controversial.
|
4 |
One is compulsory licensing of IP rights, with
|
5 |
or without royalty fees. The case that springs to mind
|
6 |
involving forced licensing is the Xerox case brought by
|
7 |
the FTC in 1975. The FTC in that case imposed a
|
8 |
compulsory licensing obligation on Xerox. In Microsoft,
|
9 |
as Bill just mentioned, there was also a compulsory
|
10 |
disclosure of information component in the decree as
|
11 |
well Microsoft was required to disclose its APIs and
|
12 |
also its communications protocol.
|
13 |
Another typical affirmative duty is the
|
14 |
obligation to sell to all customers on a
|
15 |
non-discriminatory basis, and that was part of the order
|
16 |
in the Ninth Circuit Kodak case.
|
17 |
The third example that I have listed on the
|
18 |
slide is also not terribly controversial, and that is
|
19 |
unbundling. For example, in United Shoe, the defendant
|
20 |
was required to unbundle its machinery and its repair
|
21 |
service.
|
22 |
The fourth category is probably the most
|
23 |
controversial, and that is requiring the defendant to
|
24 |
create products to comply with industry standards and
|
25 |
not just with its own proprietary standard. This is the |
72
1 |
remedy that the State of Massachusetts asked the court
|
2 |
to impose in Microsoft, in the case that Massachusetts
|
3 |
continued to pursue after Microsoft settled with the
|
4 |
DOJ. Incidentally, the District Court did not grant
|
5 |
that request.
|
6 |
I was going to talk about the Korean Microsoft
|
7 |
case, which I found very interesting, but I don't think
|
8 |
I will have time for that, so let me just end with two
|
9 |
points. I have alluded to the first point earlier, and
|
10 |
that is the usefulness of a continuing jurisdiction
|
11 |
clause in a remedial order. Perhaps those of you who
|
12 |
are still in government can enlighten me as to why the
|
13 |
government does not seem to want to include these
|
14 |
jurisdiction clauses in their remedies anymore, back in
|
15 |
the 1950s and 1960s.
|
16 |
Having a continuing jurisdiction clause is
|
17 |
helpful in a dynamic high technology market because it
|
18 |
allows the court to assess the success of the remedy,
|
19 |
and to assess future development. The purpose of
|
20 |
assessment is not so much to ensure that strict
|
21 |
compliance with the decree itself is occurring, although
|
22 |
that is very important too, but to ensure that there's
|
23 |
movement toward the ultimate objective set by the court.
|
24 |
I think Professor Hovenkamp in one of his articles
|
25 |
suggested that perhaps a continuing jurisdiction clause |
73
1 |
would be very, very helpful, because it would allow the
|
2 |
court to look at whether the decree has been successful
|
3 |
or not. I think of success as not simply whether the
|
4 |
defendant has complied with the specific terms of the
|
5 |
decree, although that is obviously a part of it, but
|
6 |
whether the decree is doing anything at all to make the
|
7 |
market more competitive.
|
8 |
One final note, and that is I think there is
|
9 |
value to Section 2 enforcement even if no effective
|
10 |
judicially-imposed remedy is available, on two
|
11 |
conditions: if there is really an egregious violation
|
12 |
of the antitrust laws, and if there is substantial harm
|
13 |
to consumer welfare. The reason enforcement is
|
14 |
important even if the violation is judicially
|
15 |
irremediable is that I think the defendants would
|
16 |
moderate their behavior somewhat, simply because
|
17 |
litigation has been brought. And they may even
|
18 |
voluntarily discontinue some of the challenged
|
19 |
practices.
|
20 |
I think it is commonly acknowledged and commonly
|
21 |
known that Microsoft relaxed enforcement of its
|
22 |
exclusive dealing contracts with the OEMs during the
|
23 |
process of the litigation. And, as far as I can tell,
|
24 |
Microsoft does not seem to be using against the type of
|
25 |
tactics that it had engaged in against Netscape and |
74
1 |
Java.
|
2 |
I am not a very tech savvy person, but it would
|
3 |
seem to me that there must be strategies similar to the
|
4 |
kinds that Microsoft had employed against Netscape and
|
5 |
Java, and yet they have not engaged in them against
|
6 |
Google. Of course we will never know how much of their
|
7 |
reticence is the result of the deterrent effect of the
|
8 |
government's enforcement action.
|
9 |
Finally, for public policy reasons the
|
10 |
government should not just step back and say, well,
|
11 |
there is no effective remedy, so what's the point of
|
12 |
bringing a lawsuit? If consumer harm is substantial,
|
13 |
and if the act is egregious, I think it is bad policy to
|
14 |
take no action because it sends a wrong signal. Taking
|
15 |
enforcement action can deter the Microsofts of the
|
16 |
world. Who knows, it might deter Google at some point.
|
17 |
With that, I hope I haven't repeated too much of
|
18 |
what has been said.
|
19 |
(Applause.)
|
20 |
MR. HILLEBOE: Thanks, Marina. This is the
|
21 |
portion of the hearing where we allow each of the
|
22 |
speakers to comment with what they've heard before, and
|
23 |
I'll start with Howard, please.
|
24 |
MR. SHELANSKI: Well, I thought a number of the
|
25 |
presentations raised provocative, extremely provocative |
75
1 |
issues.
|
2 |
Let me start with Michael Cunningham's comments
|
3 |
about the problems that companies like Red Hat still
|
4 |
face, even in the wake of the decree.
|
5 |
I found his comments extremely interesting,
|
6 |
because they suggested both at the same time a need to
|
7 |
be very aggressive against anticompetitive behavior,
|
8 |
because it has lasting effects, but also to raise real
|
9 |
questions about what can be done about those effects,
|
10 |
and if one were to translate that into a recommendation
|
11 |
about remedies, it would be hard to know -- it would be
|
12 |
hard to know exactly what the result is.
|
13 |
On one hand, it might be taken to suggest that
|
14 |
we need very aggressive kinds of remedies of the kinds
|
15 |
that Professor Lao just suggested, with continuing
|
16 |
supervision, and more creative solutions to lowering
|
17 |
rivals' costs.
|
18 |
On the other hand, I think that Bill Page raised
|
19 |
very good reservations that I share about pursuing that
|
20 |
kind of aggressive oversight.
|
21 |
So, where I come out from Michael's comments is
|
22 |
to say that we do need to pursue these cases. We need
|
23 |
to pursue these cases to understand what kind of conduct
|
24 |
is likely to lead down the road to problems that are
|
25 |
very hard to uproot. And in concert, I think, with what |
76
1 |
Professor Lao just suggested, even if we're not sure
|
2 |
that the remedy will work, pursue the case so that next
|
3 |
time around, we can uproot the conduct earlier and have
|
4 |
a remedy that will be effective, but I think, Michael,
|
5 |
you pointed to some really very difficult challenges.
|
6 |
With regard to Renata Hesse's comments, I think
|
7 |
I shared very, very much your point of view. I think
|
8 |
you were a little bit more cautious about the likelihood
|
9 |
of success of injunctive remedies, I thought you raised
|
10 |
some very good points there, but I continue to think
|
11 |
that particularly in the high-tech sector, injunctive
|
12 |
remedies will take the form of a negative prohibition of
|
13 |
thou shalt not are likely to be the most fruitful
|
14 |
remedial avenue overall.
|
15 |
Professor Page, I found that story fascinating,
|
16 |
but I think the detail was extremely instructive, and
|
17 |
very helpful. And I guess on one hand, I might be
|
18 |
inclined to say, well, does that mean we shouldn't go
|
19 |
deep into these kinds of continuing remedies; on the
|
20 |
other hand, I might say, well, maybe this is very costly
|
21 |
to Microsoft, with little benefit to competitors, but
|
22 |
maybe costly to Microsoft in and of itself, isn't so
|
23 |
bad.
|
24 |
But maybe costly to Microsoft in and of itself
|
25 |
isn't so bad. Maybe it's a very back-handed form of |
77
1 |
disgorgement remedy through the front door.
|
2 |
I say that partly tongue in cheek, because I
|
3 |
don't know that they really notice that kind of spare
|
4 |
change over there.
|
5 |
(Laughter.)
|
6 |
MR. SHELANSKI: No, but it does raise some very
|
7 |
serious questions about how even the most carefully
|
8 |
wrought and technologically sophisticated attempt at an
|
9 |
affirmative remedy can be very difficult, and that's a
|
10 |
lesson that I take very much to heart. So, I've learned
|
11 |
a lot from all of you. Thanks, very interesting.
|
12 |
MR. HILLEBOE: Thank you very much, Howard.
|
13 |
Renata?
|
14 |
MS. HESSE: Sure. I think -- I don't think the
|
15 |
mic' is on. I think the thing that I took away from
|
16 |
everyone's comments was very similar to what Howard just
|
17 |
said, was that there seems to be a sort of inherent
|
18 |
conflict between these two views of both the difficulty
|
19 |
and in some cases I think impossibility of imposing
|
20 |
remedies in technology markets, and yet at the same time
|
21 |
the view that we really need to keep trying, even though
|
22 |
we're not likely to be successful.
|
23 |
And I haven't come up with a good way of
|
24 |
bringing those two points of view together, other than
|
25 |
to say that I think, you know, courts, and not in the |
78
1 |
antitrust context, but in lots of other contexts, have
|
2 |
over the years dealt with a lot of very difficult
|
3 |
issues, which people, I think, over time, have thought,
|
4 |
well, you know, how could a court ever figure out how
|
5 |
to -- I'll use, you know, prison conditions litigation,
|
6 |
which I think I talked about before, you know, school
|
7 |
desegregation is another one.
|
8 |
Difficult problems that are not within the core
|
9 |
competency of either courts or lawyers, and everybody, I
|
10 |
think, has thought that a social benefit derives from
|
11 |
intervention in those areas, and at least an attempt to
|
12 |
try to solve them in some way.
|
13 |
And I don't really see technology markets as
|
14 |
being different in any -- I mean, they're obviously
|
15 |
different in terms of the substance that they deal with,
|
16 |
but not different in terms of the importance of the
|
17 |
issues that you're dealing with, in terms of the
|
18 |
importance of markets to both not just America's
|
19 |
economy, but the world economy, and to the every day
|
20 |
consumer. I mean, these products and services are
|
21 |
things that we all use on a daily basis, and spending
|
22 |
time thinking about, A, whether or not the law is being
|
23 |
violated in those areas, and B, if it is being violated,
|
24 |
how can you do the very best job you can to try and
|
25 |
solve the problem seems to me to be a worth while |
79
1 |
expenditure of not only government time, but also in
|
2 |
some cases in private litigation time, too.
|
3 |
Keep at it, I guess, is my final conclusion.
|
4 |
MR. HILLEBOE: Michael, and also I would ask you
|
5 |
to address your points of the speed and cost of
|
6 |
antitrust litigation are duly noted. If you have any
|
7 |
profound suggestions with respect to those or practical
|
8 |
suggestions or any other type of suggestions.
|
9 |
MR. ELIASBERG: Or those quick and speedy cases,
|
10 |
I was very interested in that.
|
11 |
MR. CUNNINGHAM: Right, profound thoughts
|
12 |
probably won't be forthcoming, but I will try and offer
|
13 |
a couple. I take a pretty simple approach as a business
|
14 |
person. I have a difficult problem, I keep working on
|
15 |
it and keep attacking it until I come up with a
|
16 |
solution.
|
17 |
I think, you know, serious examination of the
|
18 |
effects of the Microsoft remedies is worth while, but
|
19 |
there is assuredly deterrent value. One part of the
|
20 |
advice that I tell my client, which I didn't mention
|
21 |
before, is that I believe it assuredly moderates
|
22 |
behavior for us to have any participation and then for
|
23 |
the case to be brought at all.
|
24 |
Indeed, in the area of some of the protocols
|
25 |
that have been licensed that Bill referred to, I deeply |
80
1 |
wonder whether Microsoft would have reached out to Red
|
2 |
Hat and requested our assistance and consultation in
|
3 |
producing a very, very simple protocol license that's
|
4 |
one page, we'll never know the cause/effect of both the
|
5 |
EU action and the U.S. action, but there's reason to
|
6 |
think that some of that may moderate behavior.
|
7 |
I think in the case of Bill's examination, also,
|
8 |
I would just comment that continuing to look at those
|
9 |
facts are important. For example, Bill pointed out that
|
10 |
there are other ways to interoperate. Other ways to
|
11 |
interoperate that are fundamentally disadvantaged is not
|
12 |
interoperation. It doesn't work.
|
13 |
The IT community, you know, competes on the
|
14 |
speed, efficiency, and look and feel of interoperation.
|
15 |
So, simply concluding that there may be other protocols
|
16 |
out there that may have issued since the decree, at
|
17 |
least some of them, may not be complete examination. I
|
18 |
should point out, Bill was kind enough to provide me a
|
19 |
draft of his entire paper, which I didn't have a chance
|
20 |
to look at before, so if it's addressed in the paper, my
|
21 |
apologies.
|
22 |
I think that, you know, these are terribly hard
|
23 |
problems to work on, and I just don't see where, without
|
24 |
learning and gaining experience in how to better address
|
25 |
conduct remedies, we're able to make effective inroads |
81
1 |
into some of these fast-moving markets.
|
2 |
MR. HILLEBOE: Bill?
|
3 |
MR. PAGE: I just have a few kind of stray
|
4 |
comments. I was struck by Renata's point about focusing
|
5 |
on a remedy early, and I agree that that is really
|
6 |
critical, and I would suggest that particularly in a
|
7 |
case that ends in a consent decree, before litigation,
|
8 |
it's absolutely essential.
|
9 |
What I -- part of the problem I saw in the
|
10 |
Microsoft remedial issue was that the case lasted so
|
11 |
long that it was a moving target to think about the
|
12 |
remedy, you know, that at -- that by the time the case
|
13 |
was over, the remedy that people wanted was different
|
14 |
from the one they would have predicted early in the
|
15 |
litigation.
|
16 |
So, you know, particularly for cases that last
|
17 |
longer than just a couple of years, it's particularly
|
18 |
difficult to be sure the remedy from the outset and be
|
19 |
building a factual basis for it.
|
20 |
I think the point about avoiding mandatory kinds
|
21 |
of remedies as opposed to prohibitory remedies is a
|
22 |
valid one. I would just caution, though, that in the
|
23 |
Microsoft case, there was another mandatory remedy to
|
24 |
reveal the APIs that Microsoft uses to interact with its
|
25 |
middleware, between the Windows operating system and its |
82
1 |
middleware, and that one seems not to have caused that
|
2 |
many problems. And I suspect that the reason for that
|
3 |
is that Microsoft's whole business is marketing APIs,
|
4 |
and documenting APIs. If they couldn't do that, they
|
5 |
wouldn't be in business.
|
6 |
So, that was a much more straightforward problem
|
7 |
than marketing protocols, their own proprietary
|
8 |
protocols, and I think that's, you know, perhaps that
|
9 |
explains some of the difficulties that have been found
|
10 |
in documenting that.
|
11 |
So, not all mandatory types of relief will
|
12 |
necessarily be as problematic as this one. On the issue
|
13 |
of the technical committee, I want to combine this with
|
14 |
the idea that the courts should retain jurisdiction, and
|
15 |
periodically review the experience in enforcement. The
|
16 |
technical committee I think is one institutional concern
|
17 |
that I have about the technical committee, certainly
|
18 |
they are quite expert. I know nothing about them
|
19 |
individually, but certainly no one would challenge their
|
20 |
technical capacity, but they were given a single task,
|
21 |
and that was to assure that the documentation is first
|
22 |
rate, flawless. And, you know, as Howard pointed out,
|
23 |
who cares how much Microsoft pays, to do that, and so
|
24 |
it's a very expensive process to meet that kind of
|
25 |
standard. |
83
1 |
On the other hand, I think at some point, the
|
2 |
court should come back and ask the question, is this
|
3 |
accomplishing as much as we could accomplish in other
|
4 |
ways? In other words, the economic question is always
|
5 |
compared to what? And particularly if we can
|
6 |
preemptively think about these issues before they come
|
7 |
up, but also, if we can think about them down the road,
|
8 |
perhaps as an opportunity for mid-course corrections
|
9 |
that could reduce costs and perhaps benefit the market
|
10 |
better.
|
11 |
Just finally, on the issue of whether high
|
12 |
technology markets require or it's more appropriate to
|
13 |
use remedies in them because of network effects, I would
|
14 |
only caution that the literature on network effects
|
15 |
doesn't exactly say that competition doesn't work in
|
16 |
these markets. It doesn't necessarily say that network
|
17 |
effects are bad, I mean, when you think about it,
|
18 |
network effects are simply economies of scale on the
|
19 |
demand side. In other words, they benefit consumers,
|
20 |
and so the concern that they are simply a barrier to
|
21 |
entry I think somewhat overstates the case.
|
22 |
Markets converge on a single standard for
|
23 |
reasons that are actually beneficial to consumers. It
|
24 |
doesn't necessarily follow, then, that government
|
25 |
intervention is necessary, and I would add to that the |
84
1 |
issue of compatibility is also not so simple, because
|
2 |
markets characterized by network effects can sometimes
|
3 |
compete very effectively with totally incompatible
|
4 |
systems, as we observed in the video game console market
|
5 |
where, you know, it's a constant leapfrog competition of
|
6 |
totally incompatible systems of hardware and software.
|
7 |
And that is a very effective model for competition.
|
8 |
So, it doesn't necessarily follow that we should
|
9 |
be promoting interoperability in all circumstances.
|
10 |
MR. HILLEBOE: Marina?
|
11 |
MS. LAO: I actually only have a few comments.
|
12 |
I think the presentations today highlight the
|
13 |
difficulties involved. For instance, Bill's
|
14 |
presentation focused on the problems that I had tried to
|
15 |
shy away from, and that is there are major difficulties
|
16 |
in using and implementing forward-looking remedies.
|
17 |
And Michael's points, I think, drive home the
|
18 |
need, for more active government intervention, because I
|
19 |
think private Section 2 cases are extremely difficult to
|
20 |
prove, especially since proving anticompetitive effects
|
21 |
now often requires economic proof. When the violation
|
22 |
involves technology that hasn't fully emerged yet, it's
|
23 |
very difficult to show that there is actual
|
24 |
anticompetitive effect. I pretty much agree with most
|
25 |
of what Renata and Howard said. |
85
1 |
MR. HILLEBOE: Okay, thank you.
|
2 |
Bill, just as a point of clarification, I think
|
3 |
you had indicated that Microsoft was licensing its
|
4 |
source code. Just to clarify that, I think you probably
|
5 |
mean it's licensing portions of its source code that are
|
6 |
associated with interoperability issues. Is that
|
7 |
correct?
|
8 |
MR. PAGE: It's allowing licensees of the
|
9 |
protocols access to the source code in order to help
|
10 |
them use the protocols.
|
11 |
MR. HILLEBOE: Right, but not the crown jewels,
|
12 |
so to speak?
|
13 |
MR. PAGE: No, they're not saying here's our
|
14 |
source code, you can use it, you know, for whatever
|
15 |
purpose, it's purely to assure -- there were some of the
|
16 |
licensees, or prospective licensee who said that they
|
17 |
really needed access to the source code, more than they
|
18 |
needed the specification of the protocols. And I'm not
|
19 |
enough of a geek to know why that would be, but this is
|
20 |
in response to that.
|
21 |
And interestingly, that is an important
|
22 |
concession, I would say, on Microsoft's part, because
|
23 |
that was one of the proposed remedial provisions that
|
24 |
the non-settling states wanted to have added to the
|
25 |
final judgment was to require Microsoft to disclose its |
86
1 |
source code for these purposes, and the court refused to
|
2 |
order that.
|
3 |
And, so, in this limited sort of disclosure, I
|
4 |
think is an important concession.
|
5 |
MR. HILLEBOE: And several folks have talked
|
6 |
about technical committees, and I wanted to direct a
|
7 |
question to Renata about that, since she's had a lot of
|
8 |
experience with that. I was wondering, Renata, if you
|
9 |
can offer us some insights with respect to setting up
|
10 |
the technical committees, given that in a conduct
|
11 |
remedy, when you're talking about high-tech markets, and
|
12 |
given the lack of expertise of lawyers and the fact that
|
13 |
we're not engineers, and it seems almost inevitable that
|
14 |
you're going to have a technical committee, were there
|
15 |
things that you may have changed from the way you did
|
16 |
it? Also, are there any differences in the European
|
17 |
monitoring trustee? Is that a different situation? And
|
18 |
also your thoughts about having all the parties involved
|
19 |
in terms of determining who the trustee or the committee
|
20 |
should be, including the defendant?
|
21 |
MS. HESSE: I'm looking back at Patty Brink, who
|
22 |
spent a lot of time with me trying to figure out how to
|
23 |
construct the technical committee, and truthfully, it
|
24 |
was in terms of the formation of the company, it was
|
25 |
like starting a new business. So, we had to work |
87
1 |
through all sorts of issues that you wouldn't ever
|
2 |
anticipate, and we certainly didn't anticipate when we
|
3 |
thought about the provision, including how do you set up
|
4 |
a company so that it doesn't have tax liability, how do
|
5 |
you hire employees, how are they paid, all of these
|
6 |
things that none of us really knew how to do, and we
|
7 |
spent a lot of time consulting with various people to
|
8 |
figure that out.
|
9 |
The more important pieces of it, though, I think
|
10 |
really had to do with the selection of the technical
|
11 |
committee members, and if you look at the comments and
|
12 |
the response to the comments to the consent decree,
|
13 |
there were a number of people who said, whoa, you know,
|
14 |
Microsoft gets to pick and gets a role in picking at
|
15 |
least one, so the DOJ and the states picked one,
|
16 |
Microsoft picked one, and those two people picked the
|
17 |
third, and, you know, that's just, you know, they're
|
18 |
going to put one of their own people on there, and what
|
19 |
good is that really going to do.
|
20 |
And I think the interesting thing that happened
|
21 |
was that we really did find three people who were not
|
22 |
just technical experts, but also had been business
|
23 |
people, so people who had started technical companies,
|
24 |
and who really knew how to -- not only run the business
|
25 |
that they had to run, but also what the business reality |
88
1 |
of the various technical issues that they were advising
|
2 |
on.
|
3 |
And as it turned out, they really formed a
|
4 |
whole, and they worked a lot with Craig Hunt, who is the
|
5 |
nonsettling states group, who is sitting out in the
|
6 |
audience, also. And they have, you know, coalesced as
|
7 |
an entity unto themselves and the Microsoft appointee
|
8 |
plays no different role in -- the Microsoft selected
|
9 |
person plays no different role than any of the other
|
10 |
members. And I think that has been really a tremendous
|
11 |
success.
|
12 |
I think the things that one would go back and
|
13 |
look at again are the provisions in section 4 of the
|
14 |
final judgment, which is the technical committee one,
|
15 |
that relate to what the technical committee can say
|
16 |
publicly and do publicly. And this is always -- and
|
17 |
that's a big difference between the monitor trustee in
|
18 |
Europe, and the technical committee in the U.S.
|
19 |
In the U.S., the technical committee is not
|
20 |
allowed to make public statements without prior approval
|
21 |
of anybody, and their work product can't go directly to
|
22 |
the court. In terms of a compliance or enforcement
|
23 |
effort. And I think there were good, reasonable reasons
|
24 |
to do that, and I think in the end that's probably the
|
25 |
right way to do it, but in Europe, that's not how |
89
1 |
they've done it. And so their monitoring trustee
|
2 |
actually will testify at hearings about whether or not
|
3 |
Microsoft is in compliance with the final judgment.
|
4 |
And those are two very different roles, and I
|
5 |
think it's important to think about when you're
|
6 |
constructing something like this, which of those two
|
7 |
roles you want the person to play. I think having them
|
8 |
play both roles is pretty dicy.
|
9 |
MR. HILLEBOE: And I know Bill from his comments
|
10 |
expressed some skepticism about having a technical
|
11 |
committee and having another regulatory body. I was
|
12 |
wondering what the other speakers thought about having a
|
13 |
technical committee, and if they don't like that idea,
|
14 |
if they have some suggested alternatives to that.
|
15 |
Howard, do you have any thoughts about that?
|
16 |
MR. SHELANSKI: I mean, I think technical
|
17 |
committees for the reasons that Bill outlined are likely
|
18 |
to be extremely tricky, and so the only thing I have to
|
19 |
add is probably what others have said.
|
20 |
I think a technical committee should be reserved
|
21 |
for circumstances in which we have a pretty clear idea
|
22 |
of what needs to be accomplished, a pretty clear idea of
|
23 |
the market demand for that outcome.
|
24 |
MR. HILLEBOE: Michael, do you have some
|
25 |
thoughts about that? |
90
1 |
MR. CUNNINGHAM: Yeah, I personally think that
|
2 |
at least if there's going to be a conduct remedy, not
|
3 |
having a technical committee would be a fatal flaw. The
|
4 |
technology is simply too complex, too subtle and too
|
5 |
fast moving to not have, you know, that advice.
|
6 |
But turning back to some of Bill's observations,
|
7 |
the fact that the technical committee had a thousand
|
8 |
comments when they sought to implement the protocols,
|
9 |
might suggest a massive failure to comply. And, you
|
10 |
know, the fact that the technical committee ran into
|
11 |
difficulties, maybe because it's difficult, which is
|
12 |
partly true, may be difficult because people were not
|
13 |
trying to comply in good faith. I don't know.
|
14 |
MR. HILLEBOE: And Bill, did you have some
|
15 |
alternatives to having this regulatory body?
|
16 |
MR. PAGE: Just on this one last point, before I
|
17 |
answer that, most of the status reports do indicate that
|
18 |
the technical committee, or the plaintiffs, were not
|
19 |
really questioning Microsoft's effort. I mean, there
|
20 |
are occasionally comments where they're disturbed by
|
21 |
this or they're disturbed by that, but in general, the
|
22 |
tone is one of this is a huge job, and we're having
|
23 |
problems accomplishing it and we're both trying in good
|
24 |
faith to do it. That's in general what I thought from
|
25 |
these reports. |
91
1 |
And I should just say that the reports are
|
2 |
pitched at a certain level so that there's only so much
|
3 |
understanding you can get from them. And maybe if they
|
4 |
were any more technical, I wouldn't understand them at
|
5 |
all, but I'm a little bit like a denizen of Plato's
|
6 |
caves seeing the reflections of reality on the wall and
|
7 |
the reality is really outside of the cave and I can't
|
8 |
really tell for sure everything that's going on.
|
9 |
But to some degree, that is the position of the
|
10 |
court, and as Renata said, the technical committee is
|
11 |
sealed off from the court, which means that its
|
12 |
observations need to be mediated by the lawyers, who I
|
13 |
suspect probably don't understand the technical issues
|
14 |
much better than I do, and I think that's a problem.
|
15 |
I mean, we have this technical body that does
|
16 |
understand the issues from a technical point of view,
|
17 |
but their antitrust significance has to be mediated by
|
18 |
people who essentially don't. And I think that's a --
|
19 |
that's a difficulty that perhaps wouldn't be the case if
|
20 |
we had a more conventional administrative agency where
|
21 |
expertise were, you know, the problems of addressing
|
22 |
expertise and using it in decision-making were more
|
23 |
formally, you know, implemented.
|
24 |
MR. HILLEBOE: Marina, do you have any thoughts
|
25 |
on this? |
92
1 |
(No response.)
|
2 |
MR. HILLEBOE: Okay. You know, one of the
|
3 |
outstanding features of these types of markets that we
|
4 |
look for are the presence of network effects, and some
|
5 |
people have discussed this, but I think it's important
|
6 |
to cover this. Is there a consensus with respect to in
|
7 |
markets where you have network effects, are those
|
8 |
markets that tend toward monopoly or toward a
|
9 |
winner-take-all or winner-take-most equilibrium, or some
|
10 |
people have suggested that, or is that overly simplistic
|
11 |
or is that a capricious argument. What are your
|
12 |
thoughts on that, Howard?
|
13 |
MR. SHELANSKI: Well, first let me say that I
|
14 |
think that the markets that are truly likely to tip to
|
15 |
monopoly are few. I think it's a fairly circumstance
|
16 |
where a network market will precipitously tip to
|
17 |
monopoly, but it can happen.
|
18 |
Not all cases where network market tips to
|
19 |
monopoly yield bad outcomes. First of all, those
|
20 |
monopolies can be unstable. There's a fair amount of
|
21 |
research that actually shows that network markets
|
22 |
flip-flop more frequently under some conditions than is
|
23 |
good for consumers. Because they're stuck with legacy
|
24 |
technologies that don't migrate forward to the product
|
25 |
of new innovator. |
93
1 |
So, I think that just because something is a
|
2 |
network market doesn't mean that we need to worry about
|
3 |
some kind of tragedy of tipping. But it -- it can
|
4 |
happen. And then where it does happen, I think that the
|
5 |
remedial problem is really a challenging one. The
|
6 |
structural remedy can break up network effects,
|
7 |
interoperability remedies can lead to the need for
|
8 |
behavioral oversight, but also, we want to be careful, I
|
9 |
think one of the commentators, it might have been Bill,
|
10 |
pointed out, we don't necessarily want to mandate
|
11 |
interoperability, even when recommending a network
|
12 |
market, because new standards come into the market that
|
13 |
could improve things for people and you don't want to
|
14 |
eliminate the incentive to try to create the new network
|
15 |
standard.
|
16 |
So, I think network monopolies can arise, one
|
17 |
should not presume that they are too easily going to tip
|
18 |
to monopoly, even though their demand side of positive
|
19 |
externalities. We've seen cases where multiple systems
|
20 |
exist, and where they do exist, I think the remedy needs
|
21 |
to be thought about very carefully. Structural remedies
|
22 |
can be risky, interoperability is not always worth
|
23 |
mandating.
|
24 |
So, in those markets, it would seem the simplest
|
25 |
and baseline remedy would be if there is some kind of |
94
1 |
conduct that is clearly putting impediments in the paths
|
2 |
of an innovator, enjoin that conduct, whether you go
|
3 |
farther and engage in structural relief or mandate to
|
4 |
interoperability should be undertaken with extreme
|
5 |
caution.
|
6 |
MR. HILLEBOE: Renata, did you want to comment?
|
7 |
MS. HESSE: I guess I think that the presence of
|
8 |
network effects in a market does at least open up the
|
9 |
door for the suggestion that the market may be more
|
10 |
susceptible to a monopoly -- to monopoly power being
|
11 |
exercised, or existing. I also think that network
|
12 |
effects can benefit consumers in many ways. So, there's
|
13 |
a hard balance there, because you don't -- you honestly
|
14 |
don't want to do something that will then take away the
|
15 |
benefit of the network effect that the consumer derives.
|
16 |
But I think they tend to raise barriers to entry,
|
17 |
whether or not those are long-standing and durable
|
18 |
barriers is I think the really big question, and if they
|
19 |
are, how you fix them.
|
20 |
MR. HILLEBOE: And Michael is somebody who is
|
21 |
out in those markets every day. What's your view?
|
22 |
MR. CUNNINGHAM: I'm not sure I can provide a
|
23 |
broad across the industry, certainly the network effects
|
24 |
in the markets we participate in is a very, very
|
25 |
profound -- has very profound effects on competition. |
95
1 |
So, I also can recognize that there are consumer
|
2 |
benefits to it and I agree with Howard's comments that
|
3 |
it probably presents some special challenges in
|
4 |
structuring a remedy and that certainly structural
|
5 |
remedies could present some real issues.
|
6 |
MR. HILLEBOE: And Michael, precisely how do you
|
7 |
think they affect competition if they present a barrier
|
8 |
to entry? Is that essentially what you said?
|
9 |
MR. CUNNINGHAM: Yeah, they present a barrier to
|
10 |
entry. I think they also, because they present a
|
11 |
barrier to entry, they permit, you know, migration into
|
12 |
adjacent markets.
|
13 |
MR. HILLEBOE: And Bill?
|
14 |
MR. PAGE: One of the observations that was made
|
15 |
fairly early in the effort to integrate antitrust and
|
16 |
network effects, and I think it was Mark Rome who stated
|
17 |
it, one of the observations that had been made was that
|
18 |
when you're in this period of standards competition, in
|
19 |
between two incompatible standards and it's not entirely
|
20 |
clear which is going to become the dominant standard,
|
21 |
there's a huge incentive for firms to engage in
|
22 |
practices that don't look rationale. Penetration
|
23 |
pricing, giving stuff away for free, and so forth, and
|
24 |
part of the difficulty is that if you look down that
|
25 |
list of things that they have the incentive to do, a lot |
96
1 |
of them look like antitrust violations. You know, it's
|
2 |
just rational to engage in practices that can look like
|
3 |
antitrust violations, and what they are is standards
|
4 |
competition, they're exactly what the literature would
|
5 |
predict as standards competition.
|
6 |
So, that is a serious dilemma for applying the
|
7 |
antitrust laws in these markets. On the other hand, you
|
8 |
know, one of the -- one of the supposed paradoxes in the
|
9 |
Microsoft case was, you know, who cares who the
|
10 |
Microsoft or Java, for example, wins, or Netscape/Java,
|
11 |
or Netscape alone, because all you'll have is just the
|
12 |
new monster. And who cares? You know, you'll just wind
|
13 |
up with one firm dominating the market and you'll have a
|
14 |
monopoly and so what.
|
15 |
And I think there's a very good answer to that,
|
16 |
that actually came up in the oral argument in the
|
17 |
Microsoft case, and that I take that the Court of
|
18 |
Appeals accepted, because they didn't even discuss it in
|
19 |
their opinion, and that is that you don't want a biased
|
20 |
choice. In other words, it does matter who wins.
|
21 |
You're going to have a monopolist, it does matter which
|
22 |
is the monopolist, and the network effects, the
|
23 |
literature would suggest, that in some circumstances,
|
24 |
network effects can exclude even a product that's better
|
25 |
setting aside the network advantage. |
97
1 |
So, you know, I'm not sure exactly where to come
|
2 |
down on it. Mark had a few suggestions, in his article
|
3 |
that was in Connecticut, and I don't remember the name
|
4 |
of it, but he had a few suggestions on how to, for
|
5 |
example, distinguish conventional with the sort of the
|
6 |
predicted penetration pricing from genuine predatory
|
7 |
pricing and how that might be adapted to network
|
8 |
markets.
|
9 |
MR. HILLEBOE: Marina, do you have any thoughts
|
10 |
on that?
|
11 |
MS. LAO: I think it's true that network effects
|
12 |
can be very efficient, and the example that I'm thinking
|
13 |
of is not a high-tech one, but is real estate
|
14 |
multi-listing. No one would say that the network
|
15 |
effects there are not efficient, and agree that in
|
16 |
remedies where network effects are efficient, we have to
|
17 |
be very sure -- we have to be very careful not to take
|
18 |
away the efficiencies.
|
19 |
So, for instance, in the real estate
|
20 |
multi-listing situation, perhaps you could force the
|
21 |
network to open itself up to competitors, but not try to
|
22 |
introduce a competing network.
|
23 |
MR. HILLEBOE: And moving on to sort of --
|
24 |
MR. CUNNINGHAM: Just one final thought.
|
25 |
MR. HILLEBOE: Sure. |
98
1 |
MR. CUNNINGHAM: Just on the idea of preserving
|
2 |
innovation through standards competition, perhaps
|
3 |
apropos my principal comments, innovation also occurs
|
4 |
through open collaboration about open standards and
|
5 |
there's ample evidence about that. So, I think it's a
|
6 |
factor, but I don't think it's the only factor that
|
7 |
needs to be considered in that circumstance.
|
8 |
MR. HILLEBOE: Moving on to kind of a nuts and
|
9 |
bolts issue, Renata suggested that given the speed of
|
10 |
change in these markets, that perhaps a shorter consent
|
11 |
decree might be appropriate. Is that something that as
|
12 |
an antitrust enforcement agency we should be thinking
|
13 |
about?
|
14 |
Howard?
|
15 |
MR. SHELANSKI: Maybe I'm too optimistic about
|
16 |
the ability to advise consent decrees, I should know
|
17 |
better, I think I litigated waiver number 917 on the NIT
|
18 |
decree, but I'm not sure that I would shorten the decree
|
19 |
for the following reason, and I mean, I defer to you who
|
20 |
implement these daily to know better, but it would seem
|
21 |
to me that if it was easier to repeal and modify a
|
22 |
decree than to re-authorize one or to negotiate a new
|
23 |
one, I might put one in place for a longer period of
|
24 |
time and back off if it becomes moot and then go in the
|
25 |
other direction. That's an enforcement question I'm not |
99
1 |
qualified to answer.
|
2 |
MR. ELIASBERG: If I could follow up on that one
|
3 |
with Howard. Howard, there were allusions to some sort
|
4 |
of a review process, in which the court or somehow or
|
5 |
another would open up the decree, not to see to
|
6 |
necessarily compliance with the decree, but with the
|
7 |
effectiveness of the decree. How would you factor that
|
8 |
into this whole question of term of decree?
|
9 |
MR. SHELANSKI: Well, I think it's a great idea,
|
10 |
and I would favor a review provisions, or, you know,
|
11 |
eventual sunset provisions in the absence of review.
|
12 |
But review, you know, review is very difficult. You
|
13 |
know, I'm not sure the second and third triennial
|
14 |
reviews under the AT&T decree ever occurred, and so --
|
15 |
and then the question of, well, what gives cause, what
|
16 |
gives cause to open them up, but having them there in a
|
17 |
decree so that someone can go get a mandamus and seek
|
18 |
relief.
|
19 |
MR. HILLEBOE: Do any other speakers have any
|
20 |
thoughts about that?
|
21 |
Yes, Bill?
|
22 |
MR. PAGE: I think in principle, I like short
|
23 |
decrees. On the other hand, it's a bit of a catch-22
|
24 |
when you're talking about the compulsory licensing
|
25 |
provisions, because how do you market to firms the idea |
100
1 |
of building on, say, Microsoft's proprietary base, if
|
2 |
the license is going to expire in a few years? I mean,
|
3 |
how -- that seems to be like a contradictory -- I mean,
|
4 |
not that firms would ever necessarily want to be
|
5 |
building on Microsoft's proprietary protocols, in many
|
6 |
instances, they might choose not to do that even if they
|
7 |
were thought to be perpetual licenses, but I would be
|
8 |
concerned that at some point, the government is going to
|
9 |
leave the picture and Microsoft is going to yank my
|
10 |
protocols under the basis of my whole business.
|
11 |
So, you know, I guess it depends -- to my way of
|
12 |
thinking, it would depend on the nature of the remedy.
|
13 |
If it's a prohibitory remedy to remove specific
|
14 |
impediments, that would make sense for that to just be a
|
15 |
short-term one. But if there is a legitimate need for a
|
16 |
forward-looking remedy, then I think, you know, five
|
17 |
years is probably not enough, and certainly it hasn't
|
18 |
been enough in the protocol licensing provision.
|
19 |
MR. SHELANSKI: Can I just follow up really
|
20 |
quickly on that?
|
21 |
MR. HILLEBOE: Of course.
|
22 |
MR. SHELANSKI: I think Bill makes a good point,
|
23 |
I think the nature of the conduct really in some sense
|
24 |
has to derive what the length of the decree is. For
|
25 |
example, suppose somebody gets a network monopoly by |
101
1 |
penetration pricing, and now they get zero, and then
|
2 |
they undertake some type of conduct later once they have
|
3 |
their monopoly that prevents subsequent innovators by
|
4 |
doing the same thing, by exclusive dealing or something
|
5 |
else like that. I'm not sure that you want a short
|
6 |
decree there, because it's quite clear that the conduct
|
7 |
will always be harmful, and so I think tying it to the
|
8 |
conduct, there might not be a systematic answer.
|
9 |
MR. ELIASBERG: Actually, if I can follow up
|
10 |
with Renata, I think Renata you initially raised this
|
11 |
point. What are your thoughts on how to determine if a
|
12 |
shorter decree is appropriate, and also just how long
|
13 |
that shorter decree ought to be.
|
14 |
MS. HESSE: That's asking me impossible
|
15 |
questions. I actually agree with both Bill and Howard
|
16 |
that what kind of conduct it is that you're talking
|
17 |
about is going to be an important input into that
|
18 |
determination. It's clear that the five years was not
|
19 |
enough, for the section of the consent decree, or that
|
20 |
at least both Microsoft and all the plaintiffs came to
|
21 |
the conclusion that they needed more time.
|
22 |
So, and then there was a lot of work done, which
|
23 |
I think if you, you know, scour the status reports,
|
24 |
you'll see they're done to make sure that this problem
|
25 |
that Bill talked about, which was why would I invest in |
102
1 |
this to begin with if it's going to get yanked out from
|
2 |
under me in the end, to see that the terms of the
|
3 |
licenses were flexible enough so that hopefully people
|
4 |
felt comfortable with that.
|
5 |
I think that the kinds of things to think about
|
6 |
when you're trying to decide whether or not a shorter or
|
7 |
longer decree makes sense have to do with both the way
|
8 |
in which the market changes, how quickly you think the
|
9 |
market is going to change, whether or not that matters
|
10 |
for the ultimate success of the remedy, whether or not
|
11 |
you think that there's a sort of simple one-shot
|
12 |
solution to the problem, and that if somebody can -- if
|
13 |
the particular conduct, if stopped for a period of time
|
14 |
will result in new entry, or in a lowering of a barrier
|
15 |
to entry that will be sufficient in a short period of
|
16 |
time to overcome the prospect of the network effect.
|
17 |
I think in most technology markets, despite the
|
18 |
fact that they move fast, this issue that Bill raised
|
19 |
about there being an underpinning in the monopolist's
|
20 |
technology that may be an important part of alleviating
|
21 |
the anticompetitive or the harm from the anticompetitive
|
22 |
conduct, would tend to suggest that shorter decrees
|
23 |
actually are not warranted in most cases.
|
24 |
On the other hand, you know, I think both of the
|
25 |
agencies have gone away from the idea of doing perpetual |
103
1 |
decrees, ten years is generally the standard. So,
|
2 |
you're talking about the difference between five and ten
|
3 |
years, and it's hard to know precisely in what cases it
|
4 |
makes sense to do one or the other I guess.
|
5 |
MR. HILLEBOE: I thought Howard made an
|
6 |
interesting point, and it's something that we touched on
|
7 |
yesterday, but we kind of had a truncated discussion on
|
8 |
it, and that is I think there's a recognition frequently
|
9 |
in a case you see perceived liability, but you recognize
|
10 |
that it's going to be very difficult to come up with a
|
11 |
remedy. And the question what is the value of
|
12 |
proceeding and prosecuting that type of a case, and the
|
13 |
possible goals might be for deterrence, as Howard
|
14 |
suggested, or for establishing a precedent, or for
|
15 |
making it easier to bring a subsequent case.
|
16 |
I know Howard's view on that, but what do the
|
17 |
other speakers think about that? Renata, do you have
|
18 |
any thoughts about that? Or do you want to punt that
|
19 |
one?
|
20 |
MS. HESSE: How about this, why don't we start
|
21 |
down there, so Marina can go first.
|
22 |
MR. HILLEBOE: Marina?
|
23 |
MS. LAO: I believe that we should proceed if
|
24 |
the violation is egregious and if the consumer harm is
|
25 |
substantial, but where it is not substantial, and where |
104
1 |
the act is borderline, then if we don't have a clear
|
2 |
remedy that is workable, then perhaps we should back
|
3 |
off.
|
4 |
MR. HILLEBOE: So, sort of a sliding scale in
|
5 |
your analysis?
|
6 |
MS. LAO: Sliding scale.
|
7 |
MR. HILLEBOE: Bill?
|
8 |
MR. PAGE: I would suggest that one remedy is
|
9 |
collateral estoppel, and that, you know, there are
|
10 |
plaintiffs who will not bring a case for the reasons
|
11 |
that we've just heard, that because it's simply
|
12 |
impossible to go up against the monopolist in
|
13 |
litigation, for practical terms. Just because an
|
14 |
injunctive remedy is not issued, does not necessarily
|
15 |
mean that there is not a remedial benefit, because there
|
16 |
can be follow-on litigation. I mean, the most recent
|
17 |
estimate I saw of the damages or the settlement amounts
|
18 |
in the Microsoft litigation was approaching nine billion
|
19 |
dollars. Even for Microsoft, nine billion, that will
|
20 |
get your attention.
|
21 |
So, I suspect that even establish -- and if the
|
22 |
case were brought with an eye for collateral estoppel, I
|
23 |
think there's every reason to bring a case.
|
24 |
MR. HILLEBOE: Michael?
|
25 |
MR. CUNNINGHAM: It's certainly consistent with |
105
1 |
my visceral reaction and my advice to clients, to my
|
2 |
client, that it has a deterrent effect for typically
|
3 |
even more egregious behavior. I do think there are some
|
4 |
potential evidences that the deterrent effect is real.
|
5 |
I think in addition to the complaints that Howard laid
|
6 |
out when dealing with complicated problems the
|
7 |
experience of competition authorities in learning how to
|
8 |
deal with them and getting more sophisticated in dealing
|
9 |
with them is not a value that should be discarded value.
|
10 |
MS. HESSE: Actually, I think I said this
|
11 |
earlier, I actually agree with the notion of the
|
12 |
deterrent effect of taking action, even if you're not
|
13 |
100 percent sure that you can figure out a way to solve
|
14 |
the problem perfectly, or even reasonably well, and I
|
15 |
think there are a lot of people who would say, even
|
16 |
people who will say both, that the Microsoft decree has
|
17 |
been a failure, and has done nothing, and at the same
|
18 |
time say that it was a case that was worth bringing.
|
19 |
So, and I tend to -- I'm not taking a position
|
20 |
on whether it was a failure or not, but I agree that
|
21 |
even if you assume it was a failure, that the case
|
22 |
itself, both demonstrated that these were markets that
|
23 |
the government was capable of dealing with, that they
|
24 |
were capable of litigating against a huge company and
|
25 |
winning, and that, you know, nobody was, you know, above |
106
1 |
the law. And that's an important point to make.
|
2 |
MR. HILLEBOE: Bill, I just have a question for
|
3 |
you. We talked yesterday about various goals in terms
|
4 |
of antitrust remedies, and you spent a great deal of
|
5 |
time talking about Microsoft. How would you
|
6 |
characterize, what's your opinion of what the goal was
|
7 |
for the government at the time they entered into that
|
8 |
remedy based upon reading from Charles James articles or
|
9 |
whatever, and do you think the goal was achieved?
|
10 |
MR. PAGE: You mean the consent decree?
|
11 |
MR. HILLEBOE: The 2002 consent.
|
12 |
MR. PAGE: Well, they're in a position where the
|
13 |
Court of Appeals had really given them not too much
|
14 |
choice. The thought of pursuing any type of structural
|
15 |
relief was impossible at that stage. So, at that point,
|
16 |
some sort of -- some sort of conduct was all that you
|
17 |
were going to get, and I suspect that -- well, perhaps
|
18 |
I'm not the best one to -- I'm certainly not going to
|
19 |
sort of assume what the goals were, but as I said
|
20 |
earlier, I think that by and large, the terms of the
|
21 |
consent decree and the parallel relief in the states'
|
22 |
remedy are closely tied to the theory of liability in
|
23 |
the government case.
|
24 |
Now, certainly the grandest standard by which we
|
25 |
would judge that would be does it restore the platform |
107
1 |
threat? You know, does it create some sort of rival
|
2 |
platform that would threaten Microsoft, and by that
|
3 |
standard, you would have to say that it hasn't done
|
4 |
that. On the other hand, I think there are other ways
|
5 |
of evaluating the decree. I mean, one of the provisions
|
6 |
of the decree is to make sure -- there's an internal --
|
7 |
there are two, actual, internal Microsoft compliance
|
8 |
officers, and, you know, if you go back and listen to --
|
9 |
if you go back and read Judge Jackson's comments about
|
10 |
Microsoft, it's almost he said they were like, you know,
|
11 |
young punks or organized crime or, you know, defiant
|
12 |
organization, criminal enterprise, whatever, and I don't
|
13 |
think anyone -- well, I'm not sure that anyone would
|
14 |
necessarily say that that's the case now.
|
15 |
I think at least, you know, there is a huge --
|
16 |
in fact, there is one of the status reports describes
|
17 |
the Microsoft compliance program, I think they said
|
18 |
something like -- well, they've conducted these
|
19 |
antitrust compliance seminars worldwide, 15,000
|
20 |
employees have taken them, you know, all the executives
|
21 |
are schooled in the requirements of the consent decree
|
22 |
and the antitrust laws, it may all be window dressing,
|
23 |
but I suspect that there is a difference in attitude at
|
24 |
Microsoft because of this case.
|
25 |
MR. HILLEBOE: Any of the other speakers want to |
108
1 |
comment on that?
|
2 |
MR. ELIASBERG: Yeah, a question I wanted to
|
3 |
touch base, actually, and start with you, Renata, you
|
4 |
indicated or suggested that there could be some
|
5 |
disruption to structural relief, indeed, sometimes it
|
6 |
can be cleaner and so forth. But we seem to have some
|
7 |
language from the Court of Appeals suggesting that we
|
8 |
should be extremely reluctant about thinking about
|
9 |
structural relief and indeed it should be the last
|
10 |
resort.
|
11 |
What thoughts do you have about just how
|
12 |
advisable is it for us to be thinking about structural
|
13 |
relief right out of the box with respect to such a
|
14 |
matter?
|
15 |
MS. HESSE: I think I read the Court of Appeals'
|
16 |
decision to be -- and this actually was something Bill
|
17 |
was talking about, also, to be focusing on the question
|
18 |
of causation and the importance of establishing
|
19 |
causation if you're then going to go and impose a
|
20 |
structural remedy. And that -- I think that is a very
|
21 |
important question.
|
22 |
I think the Court of Appeals' attitude toward
|
23 |
structural relief probably supports some of the things
|
24 |
that I said, which is that imposing it occasionally in a
|
25 |
Section 2 case or demonstrating that you're capable of |
109
1 |
doing that may have a greater deterrent effect, and that
|
2 |
people perceive that remedy, rightly or wrongly, to be a
|
3 |
more Draconian one than a behavioral remedy.
|
4 |
But the question of causation, I think, is
|
5 |
really an interesting one, because it does get to this
|
6 |
question of how do you know what the competitive
|
7 |
conditions of the marketplace would look like without
|
8 |
the bad exclusionary conduct? And nobody knows, really.
|
9 |
Nobody knows whether another platform effect would have
|
10 |
emerged. And so I think it's hard to say looking at at
|
11 |
least in the Microsoft context, looking at the
|
12 |
marketplace today, whether or not the decree has been a
|
13 |
booming success or, you know, an abject failure, if --
|
14 |
because you really don't know what would have happened.
|
15 |
And I think the record was -- had some information about
|
16 |
it, but I don't think anybody really knew whether
|
17 |
Netscape, in fact, was really a viable platform threat.
|
18 |
We knew that Microsoft was worried about it and thought
|
19 |
that it was.
|
20 |
So, I think I certainly wouldn't out of the box
|
21 |
say, it's not worth even spending your time thinking
|
22 |
about, because I think these cases are -- they're not
|
23 |
only hard to put together and then try, but they're very
|
24 |
difficult, and you should leave open all of your options
|
25 |
in terms of thinking about how to resolve, how to remedy |
110
1 |
a problem that you've seen and I think that, you know, a
|
2 |
structural remedy would certainly be appropriate in the
|
3 |
right cases.
|
4 |
MR. ELIASBERG: Howard, did you have something
|
5 |
you wanted to add?
|
6 |
MR. SHELANSKI: Well, my tongue-in-cheek remark
|
7 |
earlier about the cost to Microsoft aside, I don't
|
8 |
believe any of us believe that the government should be
|
9 |
in the business of just creating costs for firms. So,
|
10 |
we need to be darn sure of the curative potential for --
|
11 |
I think for any remedy, and I think with a structural
|
12 |
remedy, I read the Court of Appeals, too, of being as
|
13 |
insisting on a tight causal link, and I would rephrase
|
14 |
that slightly as a strong curative likelihood of success
|
15 |
for the competitive harms.
|
16 |
And I think you want to be darn sure of that in
|
17 |
a structural setting, because especially in a high-tech
|
18 |
industry, I think the unintended consequences of
|
19 |
structural relief could be many.
|
20 |
MR. ELIASBERG: Something I also wanted to just
|
21 |
cover with the panelists, just to be sure we canvassed
|
22 |
all the views, Marina floated the notion of I'll
|
23 |
describe it as lowering rivals' costs as a strategy with
|
24 |
respect to shaping -- creating -- formulating relief. I
|
25 |
was curious if any other panelists had a reaction one |
111
1 |
way or the other about the advisability or not of such
|
2 |
imposition. You can either volunteer or I'll just go
|
3 |
ahead and call on you.
|
4 |
MR. PAGE: Well, I would say that it's
|
5 |
appropriate if it's in response to actions that
|
6 |
anticompetitively raised rivals' costs. I don't know
|
7 |
that because a violation has been found that all
|
8 |
methods, and I don't want to characterize you saying
|
9 |
this, but all methods of lowering rivals' costs have
|
10 |
been appropriate.
|
11 |
So, again, lowering rivals' costs is certainly a
|
12 |
legitimate goal, if the causal link to the
|
13 |
anticompetitive conduct is established.
|
14 |
MS. LAO: I really see that as a conduit to
|
15 |
promoting consumer welfare, and not to benefit
|
16 |
competitors for the sake of benefitting the competitors.
|
17 |
MR. SHELANSKI: As a veteran of the unbundling
|
18 |
wars in Telecom, I twitch a little bit when I hear
|
19 |
lowering rivals' costs, and I think the one thing that
|
20 |
would give me pause is I would say maybe, if the cost
|
21 |
you're lowering is one that the defendant is being asked
|
22 |
to lower through the remedy is a cost that the defendant
|
23 |
created, and I think that that would be a tie that even
|
24 |
before thinking about it I would want to see there,
|
25 |
because otherwise, I think there's really great danger |
112
1 |
for the agency to become an ongoing regulatory authority
|
2 |
as opposed to someone recommending particular
|
3 |
anticompetitive conduct.
|
4 |
MR. ELIASBERG: One more question.
|
5 |
MR. HILLEBOE: Sure.
|
6 |
MR. ELIASBERG: Actually, this one, Michael, is
|
7 |
to you. In your presentation, you made a comment about
|
8 |
situations where steps may be taken by an incumbent to
|
9 |
change structure of its product so that it could not be
|
10 |
transferability or used by a subsequent -- front by a
|
11 |
rival or something of that nature. In a case like that,
|
12 |
assuming for the moment that there was liability found,
|
13 |
found for that alteration or change in the product
|
14 |
design, what would be the type of relief you would think
|
15 |
would be -- what would be the remedy that you would
|
16 |
think would be the appropriate remedy in a situation
|
17 |
like that?
|
18 |
MR. CUNNINGHAM: In our industry, I guess with a
|
19 |
strong network effects, some interoperability remedy
|
20 |
would seem to be the one that you would need. Yeah.
|
21 |
MR. ELIASBERG: Nothing else comes to mind?
|
22 |
MR. CUNNINGHAM: No.
|
23 |
MR. ELIASBERG: Anyone else have a rationale for
|
24 |
that?
|
25 |
(No response.) |
113
1 |
MR. HILLEBOE: Well, I note that it's close to
|
2 |
12:30. So, I just want to say on behalf of the FTC, and
|
3 |
my colleagues at DOJ, I wanted to say thank you very
|
4 |
much to these speakers, an excellent presentation, and I
|
5 |
want to remind and thank everyone for coming and remind
|
6 |
everyone that we have a final wrap-up in the coming
|
7 |
weeks. Thank you.
|
8 |
(Applause.)
|
9 |
(Whereupon, at 12:28 p.m., the hearing was
|
10 |
adjourned.)
|
11 |
|
12 |
|
13 |
|
14 |
|
15 |
|
16 |
|
17 |
|
18 |
|
19 |
|
20 |
|
21 |
|
22 |
|
23 |
|
24 |
|
25 |
|
114
1 |
C E R T I F I C A T I O N O F R E P O R T E R
|
2 |
|
3 |
DOCKET/FILE NUMBER: P062106
|
4 |
CASE TITLE: SECTION 2 HEARINGS
|
5 |
DATE: March 29, 2007
|
6 |
|
7 |
I HEREBY CERTIFY that the transcript contained
|
8 |
herein is a full and accurate transcript of the notes
|
9 |
taken by me at the hearing on the above cause before the
|
10 |
FEDERAL TRADE COMMISSION to the best of my knowledge and
|
11 |
belief.
|
12 |
|
13 |
DATED: 4/3/07
|
14 |
|
15 |
SALLY JO BOWLING
|
16 |
|
17 |
C E R T I F I C A T I O N O F P R O O F R E A D E R
|
18 |
|
19 |
I HEREBY CERTIFY that I proofread the transcript
|
20 |
for accuracy in spelling, hyphenation, punctuation and
|
21 |
format.
|
22 |
|
23 |
|
24 |
SARA J. VANCE
|
25 |
|
|